Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
B.memory.preactivated: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 1,977 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TCL1A levels | PROLV002002 | 87.05 | Protein levels | B / plasma cell | 115 | 2 | 6 | 13 | |
| 2 | Ornithine metabolites | METAB000011 | 82.86 | Metabolites | B / plasma cell | 0 | 2 | 9 | 9 | |
| 3 | PARP1/TCL1A ratio | PRORT001622 | 72.74 | Protein ratios | B / plasma cell | 44 | 2 | 5 | 17 | |
| 4 | FCER2/TREML2 ratio | PRORT001123 | 72.69 | Protein ratios | B / plasma cell | 13 | 3 | 7 | 12 | |
| 5 | FCRL2 levels | PROLV000784 | 70.77 | Protein levels | B / plasma cell | 91 | 1 | 4 | 7 | |
| 6 | FCRL1 levels | PROLV000783 | 65.82 | Protein levels | B / plasma cell | 101 | 2 | 7 | 15 | |
| 7 | FCER2 levels | PROLV000777 | 65.15 | Protein levels | B / plasma cell | 112 | 3 | 9 | 24 | |
| 8 | IL5RA levels | PROLV001076 | 64.78 | Protein levels | B / plasma cell | 181 | 3 | 12 | 28 | |
| 9 | CD22 levels | PROLV000320 | 64.12 | Protein levels | B / plasma cell | 103 | 2 | 9 | 20 | |
| 10 | CD27/TNFRSF13B ratio | PRORT000418 | 63.27 | Protein ratios | B / plasma cell | 15 | 3 | 9 | 23 | |
| 11 | JCHAIN levels | PROLV001126 | 63.02 | Protein levels | B / plasma cell | 124 | 3 | 13 | 34 | |
| 12 | ZNRD2 levels | PROLV002213 | 60.73 | Protein levels | B / plasma cell | 62 | 2 | 14 | 25 | |
| 13 | FCRL5/LY96 ratio | PRORT001134 | 57.53 | Protein ratios | B / plasma cell | 39 | 5 | 15 | 23 | |
| 14 | TNFRSF13B/TNFRSF9 ratio | PRORT001847 | 56.06 | Protein ratios | B / plasma cell | 19 | 2 | 14 | 28 | |
| 15 | TCL1A/TNFRSF13C ratio | PRORT001829 | 55.86 | Protein ratios | B / plasma cell | 23 | 2 | 14 | 31 | |
| 16 | TNFRSF13B/TNFSF13B ratio | PRORT001848 | 54.78 | Protein ratios | B / plasma cell | 5 | 2 | 9 | 14 | |
| 17 | CD72 levels | PROLV000354 | 54.15 | Protein levels | B / plasma cell | 84 | 2 | 12 | 31 | |
| 18 | FCER2/TNFRSF9 ratio | PRORT001122 | 53.95 | Protein ratios | B / plasma cell | 32 | 2 | 11 | 39 | |
| 19 | TNFSF13B levels | PROLV002079 | 51.31 | Protein levels | B / plasma cell | 111 | 3 | 10 | 29 | |
| 20 | FCER2/FCRL1 ratio | PRORT001120 | 51.16 | Protein ratios | B / plasma cell | 37 | 3 | 9 | 14 | |
| 21 | CD5L levels | PROLV000348 | 50.95 | Protein levels | B / plasma cell | 208 | 2 | 11 | 26 | |
| 22 | TNFRSF13C levels | PROLV002064 | 49.46 | Protein levels | B / plasma cell | 45 | 3 | 7 | 22 | |
| 23 | KIF22 levels | PROLV001139 | 48.97 | Protein levels | B / plasma cell | 35 | 2 | 5 | 11 | |
| 24 | INPP5J levels | PROLV001090 | 48.42 | Protein levels | B / plasma cell | 8 | 1 | 7 | 21 | |
| 25 | IL18RAP levels | PROLV001057 | 46.58 | Protein levels | B / plasma cell | 20 | 2 | 5 | 6 | |
| 26 | UGDH levels | PROLV002138 | 46.32 | Protein levels | B / plasma cell | 21 | 4 | 12 | 33 | |
| 27 | SEPTIN3 levels | PROLV001813 | 44.88 | Protein levels | B / plasma cell | 64 | 3 | 5 | 25 | |
| 28 | TNFRSF13B levels | PROLV002063 | 44.37 | Protein levels | B / plasma cell | 55 | 2 | 8 | 14 | |
| 29 | Monoclonal gammopathy | HEMAT000041 | 41.91 | Hematologic | B / plasma cell | 2 | 4 | 15 | 28 | |
| 30 | Non-albumin protein levels | PROLV001459 | 41.29 | Protein levels | B / plasma cell | 766 | 3 | 12 | 26 | |
| 31 | CD22/SEMA7A ratio | PRORT000403 | 40.90 | Protein ratios | B / plasma cell | 54 | 3 | 10 | 26 | |
| 32 | CR2/TNFRSF13B ratio | PRORT000738 | 38.88 | Protein ratios | B / plasma cell | 32 | 3 | 9 | 15 | |
| 33 | FCRL5/TNFRSF13B ratio | PRORT001136 | 38.68 | Protein ratios | B / plasma cell | 59 | 4 | 15 | 23 | |
| 34 | Severe mental illness | PSYCH000017 | 38.07 | Psychiatric | Neural / glial | 0 | 4 | 8 | 10 | |
| 35 | FCER2/TCL1A ratio | PRORT001121 | 37.56 | Protein ratios | B / plasma cell | 38 | 2 | 8 | 22 | |
| 36 | CD22/TCL1A ratio | PRORT000404 | 37.05 | Protein ratios | B / plasma cell | 71 | 3 | 13 | 24 | |
| 37 | ALB/Globulin ratio | PRORT000067 | 36.82 | Protein ratios | B / plasma cell | 721 | 2 | 16 | 39 | |
| 38 | CD79B/TNFRSF13B ratio | PRORT000513 | 36.29 | Protein ratios | B / plasma cell | 14 | 2 | 5 | 6 | |
| 39 | Heme malignancy, Plasma cell | MALIG000046 | 36.06 | Malignancy | B / plasma cell | 3 | 2 | 14 | 35 | |
| 40 | FCRL1/TCL1A ratio | PRORT001126 | 35.32 | Protein ratios | B / plasma cell | 21 | 3 | 14 | 38 | |
| 41 | FCRL2/TNFRSF13B ratio | PRORT001132 | 35.23 | Protein ratios | B / plasma cell | 10 | 3 | 8 | 18 | |
| 42 | FCRL1/TREML2 ratio | PRORT001128 | 34.52 | Protein ratios | B / plasma cell | 34 | 2 | 6 | 24 | |
| 43 | FCRL2/SEMA7A ratio | PRORT001131 | 34.12 | Protein ratios | B / plasma cell | 15 | 1 | 8 | 26 | |
| 44 | Pain, limb | MSKEL000037 | 33.83 | Musculoskeletal | B / plasma cell | 1 | 5 | 10 | 20 | |
| 45 | Heme malignancy, Lymphoid | MALIG000043 | 33.21 | Malignancy | B / plasma cell | 44 | 3 | 15 | 27 | |
| 46 | SLAMF1 levels | PROLV001875 | 31.41 | Protein levels | B / plasma cell | 22 | 2 | 12 | 27 | |
| 47 | TP53BP1 levels | PROLV002090 | 31.12 | Protein levels | B / plasma cell | 66 | 2 | 10 | 28 | |
| 48 | CD27/TNFRSF9 ratio | PRORT000419 | 31.09 | Protein ratios | B / plasma cell | 20 | 5 | 15 | 40 | |
| 49 | MZB1/TNFRSF13B ratio | PRORT001568 | 29.87 | Protein ratios | B / plasma cell | 4 | 2 | 15 | 28 | |
| 50 | TNFRSF17 levels | PROLV002066 | 29.82 | Protein levels | B / plasma cell | 116 | 3 | 15 | 18 | |
| 51 | TXNDC15 levels | PROLV002124 | 28.49 | Protein levels | B / plasma cell | 86 | 4 | 19 | 38 | |
| 52 | FCRL1/TNFRSF13C ratio | PRORT001127 | 28.15 | Protein ratios | B / plasma cell | 39 | 3 | 7 | 10 | |
| 53 | PEAR1/TREML2 ratio | PRORT001661 | 27.60 | Protein ratios | B / plasma cell | 4 | 2 | 6 | 12 | |
| 54 | Primary biliary cholangitis, PBC | IMMUN000017 | 26.59 | Immunologic | Lymphocyte | 91 | 3 | 13 | 9 | |
| 55 | Liver fibrosis and cirrhosis | HPBIL000007 | 26.46 | Hepatopancreatobiliary | B / plasma cell | 11 | 4 | 13 | 32 | |
| 56 | CALCOCO1/MAP3K5 ratio | PRORT000298 | 25.92 | Protein ratios | B / plasma cell | 0 | 4 | 13 | 30 | |
| 57 | CR2 levels | PROLV000514 | 25.65 | Protein levels | B / plasma cell | 95 | 3 | 9 | 11 | |
| 58 | CD83/IL12A_IL12B ratio | PRORT000516 | 25.62 | Protein ratios | B / plasma cell | 66 | 3 | 11 | 16 | |
| 59 | QPCT/RNASET2 ratio | PRORT001726 | 25.58 | Protein ratios | B / plasma cell | 68 | 5 | 12 | 31 | |
| 60 | ICAM3/TNFRSF13B ratio | PRORT001329 | 25.57 | Protein ratios | B / plasma cell | 40 | 1 | 7 | 6 | |
| 61 | FCRL2/LY9 ratio | PRORT001130 | 25.44 | Protein ratios | B / plasma cell | 27 | 2 | 8 | 38 | |
| 62 | Heme malignancy, Chronic lymphocytic leukaemia | MALIG000041 | 25.44 | Malignancy | B / plasma cell | 53 | 3 | 15 | 32 | |
| 63 | NINJ1 levels | PROLV001406 | 25.30 | Protein levels | B / plasma cell | 21 | 2 | 10 | 19 | |
| 64 | Soft tissue disorder | MSKEL000069 | 25.24 | Musculoskeletal | Neural / glial | 21 | 2 | 7 | 6 | |
| 65 | LILRB1 levels | PROLV001213 | 24.81 | Protein levels | B / plasma cell | 214 | 5 | 14 | 33 | |
| 66 | IL5RA/TNFRSF13B ratio | PRORT001352 | 24.50 | Protein ratios | B / plasma cell | 63 | 3 | 16 | 21 | |
| 67 | PRCP levels | PROLV001624 | 24.17 | Protein levels | Myeloid | 18 | 3 | 10 | 18 | |
| 68 | TNFRSF13B/TNFRSF13C ratio | PRORT001846 | 24.15 | Protein ratios | B / plasma cell | 23 | 4 | 9 | 15 | |
| 69 | S100A11/S100A12 ratio | PRORT001753 | 24.08 | Protein ratios | B / plasma cell | 25 | 4 | 17 | 38 | |
| 70 | WASL levels | PROLV002187 | 23.67 | Protein levels | B / plasma cell | 54 | 2 | 8 | 16 | |
| 71 | Gut microbial abundance, Bifidobacterium | GASTR000019 | 23.52 | Gastrointestinal | B / plasma cell | 0 | 3 | 6 | 20 | |
| 72 | BLNK levels | PROLV000200 | 23.44 | Protein levels | B / plasma cell | 0 | 3 | 15 | 27 | |
| 73 | CD22/FCER2 ratio | PRORT000400 | 22.63 | Protein ratios | B / plasma cell | 20 | 1 | 6 | 8 | |
| 74 | SERPINA9 levels | PROLV001822 | 22.62 | Protein levels | Hepatocyte | 48 | 3 | 11 | 19 | |
| 75 | SORT1/ST6GAL1 ratio | PRORT001803 | 22.41 | Protein ratios | B / plasma cell | 24 | 5 | 11 | 22 | |
| 76 | PLXNA4/USP8 ratio | PRORT001688 | 22.37 | Protein ratios | B / plasma cell | 5 | 4 | 8 | 32 | |
| 77 | TRAF3 levels | PROLV002100 | 22.02 | Protein levels | B / plasma cell | 18 | 2 | 14 | 29 | |
| 78 | CD79B/TNFRSF4 ratio | PRORT000514 | 21.92 | Protein ratios | B / plasma cell | 45 | 3 | 16 | 20 | |
| 79 | IGLC2 levels | PROLV001035 | 21.80 | Protein levels | B / plasma cell | 51 | 3 | 15 | 23 | |
| 80 | MBL2 levels | PROLV001282 | 21.46 | Protein levels | B / plasma cell | 15 | 2 | 7 | 23 | |
| 81 | PDCD1/TNFRSF8 ratio | PRORT001630 | 21.26 | Protein ratios | B / plasma cell | 33 | 3 | 17 | 35 | |
| 82 | GART levels | PROLV000854 | 21.26 | Protein levels | B / plasma cell | 12 | 5 | 10 | 12 | |
| 83 | Systemic lupus erythematosus, SLE | IMMUN000020 | 21.00 | Immunologic | B / plasma cell | 93 | 2 | 4 | 19 | |
| 84 | PCSK7 levels | PROLV001511 | 20.96 | Protein levels | B / plasma cell | 5 | 3 | 9 | 15 | |
| 85 | CRYBB2 levels | PROLV000533 | 20.94 | Protein levels | B / plasma cell | 4 | 2 | 6 | 14 | |
| 86 | Pre-existing hypertension, pregnancy | VASCU000044 | 20.90 | Vascular | B / plasma cell | 9 | 3 | 8 | 20 | |
| 87 | MMP1/SERPINB6 ratio | PRORT001542 | 20.70 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 9 | 19 | |
| 88 | Professional qualification | SOCIO000003 | 20.53 | Socioeconomic | Neural / glial | 5 | 4 | 8 | 12 | |
| 89 | CCL5/TACC3 ratio | PRORT000359 | 20.49 | Protein ratios | Myeloid | 3 | 7 | 17 | 29 | |
| 90 | FKBP7 levels | PROLV000811 | 20.37 | Protein levels | Myeloid | 1 | 4 | 12 | 28 | |
| 91 | Hypothyroidism, secondary | ENDOC000015 | 20.33 | Endocrine | B / plasma cell | 0 | 2 | 11 | 20 | |
| 92 | MYCT1 levels | PROLV001357 | 20.31 | Protein levels | B / plasma cell | 0 | 2 | 6 | 23 | |
| 93 | CD22/FCRL1 ratio | PRORT000401 | 20.30 | Protein ratios | B / plasma cell | 100 | 2 | 15 | 25 | |
| 94 | CD27 levels | PROLV000324 | 20.23 | Protein levels | B / plasma cell | 60 | 3 | 16 | 24 | |
| 95 | ATP5IF1/LYN ratio | PRORT000159 | 20.23 | Protein ratios | B / plasma cell | 1 | 3 | 18 | 33 | |
| 96 | Vehicle ownership | SOCIO000015 | 19.99 | Socioeconomic | Neural / glial | 2 | 4 | 8 | 18 | |
| 97 | ZNF830 levels | PROLV002212 | 19.79 | Protein levels | B / plasma cell | 4 | 4 | 11 | 30 | |
| 98 | CD79B/FCRL1 ratio | PRORT000510 | 19.79 | Protein ratios | B / plasma cell | 29 | 3 | 11 | 23 | |
| 99 | MCTS1 levels | PROLV001287 | 19.49 | Protein levels | Myeloid | 59 | 3 | 10 | 14 | |
| 100 | Impacted cerumen | AUDIO000002 | 19.29 | Auditory | Salivary epithelium | 1 | 1 | 8 | 14 | |
| 101 | Hypercalcaemia | METBL000005 | 19.29 | Metabolic | Muscle / cardiac | 0 | 2 | 9 | 14 | |
| 102 | EFNA4/VWC2 ratio | PRORT000993 | 19.20 | Protein ratios | Hepatocyte | 4 | 2 | 12 | 18 | |
| 103 | Heme malignancy, Leukaemia | MALIG000042 | 19.19 | Malignancy | B / plasma cell | 7 | 1 | 4 | 14 | |
| 104 | CD22/FOLR2 ratio | PRORT000402 | 19.00 | Protein ratios | B / plasma cell | 34 | 4 | 11 | 16 | |
| 105 | FCGR2A levels | PROLV000778 | 18.91 | Protein levels | Myeloid | 62 | 3 | 9 | 13 | |
| 106 | TNFRSF13C/TNFSF13B ratio | PRORT001849 | 18.89 | Protein ratios | B / plasma cell | 32 | 3 | 7 | 28 | |
| 107 | LY96 levels | PROLV001250 | 18.87 | Protein levels | B / plasma cell | 122 | 4 | 12 | 23 | |
| 108 | CD27/TGFBR2 ratio | PRORT000417 | 18.80 | Protein ratios | B / plasma cell | 29 | 3 | 10 | 19 | |
| 109 | CD209/CLEC14A ratio | PRORT000395 | 18.71 | Protein ratios | B / plasma cell | 0 | 2 | 5 | 7 | |
| 110 | CD27/NBL1 ratio | PRORT000415 | 18.49 | Protein ratios | B / plasma cell | 23 | 3 | 12 | 25 | |
| 111 | PGR levels | PROLV001548 | 18.47 | Protein levels | B / plasma cell | 21 | 3 | 12 | 30 | |
| 112 | NUBP1 levels | PROLV001450 | 18.43 | Protein levels | B / plasma cell | 26 | 1 | 8 | 16 | |
| 113 | Educational attainment, none | SOCIO000001 | 18.42 | Socioeconomic | Neural / glial | 89 | 6 | 14 | 30 | |
| 114 | Sleep duration | PSYCH000040 | 18.17 | Psychiatric | Neural / glial | 9 | 6 | 14 | 17 | |
| 115 | Immune cell marker, pDC | HEMAT000028 | 17.95 | Hematologic | Myeloid | 0 | 3 | 12 | 14 | |
| 116 | GZMA/IL12A_IL12B ratio | PRORT001259 | 17.89 | Protein ratios | B / plasma cell | 51 | 3 | 7 | 8 | |
| 117 | CRTAP levels | PROLV000531 | 17.79 | Protein levels | B / plasma cell | 49 | 3 | 11 | 21 | |
| 118 | FCRL5/ICAM3 ratio | PRORT001133 | 17.72 | Protein ratios | B / plasma cell | 52 | 4 | 21 | 31 | |
| 119 | IL2RA levels | PROLV001069 | 17.69 | Protein levels | B / plasma cell | 106 | 3 | 16 | 27 | |
| 120 | FCRL5 levels | PROLV000786 | 17.27 | Protein levels | B / plasma cell | 201 | 5 | 17 | 23 | |
| 121 | Plasma protein metabolism disorder | METBL000029 | 17.22 | Metabolic | Hepatocyte | 26 | 2 | 6 | 24 | |
| 122 | Glycan trait | METAB000054 | 17.22 | Metabolites | B / plasma cell | 70 | 2 | 6 | 26 | |
| 123 | Middle ear and mastoid disorder | AUDIO000016 | 17.18 | Auditory | B / plasma cell | 51 | 4 | 14 | 30 | |
| 124 | Wisdom tooth surgery | DENTA000005 | 17.03 | Dental | B / plasma cell | 0 | 7 | 15 | 30 | |
| 125 | EDA2R levels | PROLV000673 | 16.97 | Protein levels | B / plasma cell | 20 | 4 | 12 | 26 | |
| 126 | CA1/CA3 ratio | PRORT000268 | 16.88 | Protein ratios | B / plasma cell | 1 | 5 | 16 | 23 | |
| 127 | Medication, immunosuppressive | IMMUN000084 | 16.70 | Immunologic | B / plasma cell | 59 | 3 | 8 | 13 | |
| 128 | CALCOCO1/CRACR2A ratio | PRORT000293 | 16.50 | Protein ratios | Muscle / cardiac | 0 | 1 | 19 | 32 | |
| 129 | PIKFYVE levels | PROLV001559 | 16.32 | Protein levels | Lymphocyte | 3 | 2 | 11 | 31 | |
| 130 | Primary sclerosing cholangitis, PSC | IMMUN000018 | 16.22 | Immunologic | B / plasma cell | 90 | 3 | 12 | 15 | |
| 131 | HNRNPK/USP8 ratio | PRORT001293 | 16.15 | Protein ratios | B / plasma cell | 0 | 2 | 9 | 18 | |
| 132 | THY1 levels | PROLV002031 | 16.03 | Protein levels | B / plasma cell | 30 | 2 | 10 | 21 | |
| 133 | C2 levels | PROLV000230 | 15.77 | Protein levels | B / plasma cell | 63 | 2 | 10 | 16 | |
| 134 | TOP1 levels | PROLV002087 | 15.62 | Protein levels | Hepatocyte | 36 | 3 | 12 | 18 | |
| 135 | Mood disorder | PSYCH000028 | 15.52 | Psychiatric | Neural / glial | 8 | 5 | 10 | 11 | |
| 136 | CD40/TNFRSF14 ratio | PRORT000447 | 15.47 | Protein ratios | Platelet | 8 | 2 | 9 | 14 | |
| 137 | CD101 levels | PROLV000308 | 15.43 | Protein levels | Lymphocyte | 57 | 2 | 17 | 43 | |
| 138 | CLPP/DECR1 ratio | PRORT000672 | 15.20 | Protein ratios | B / plasma cell | 0 | 4 | 9 | 10 | |
| 139 | GHRL levels | PROLV000886 | 15.10 | Protein levels | Hepatocyte | 39 | 2 | 6 | 15 | |
| 140 | Hereditary haemolytic anaemia | HEMAT000010 | 15.10 | Hematologic | B / plasma cell | 0 | 1 | 7 | 5 | |
| 141 | Lymphocyte | HEMAT000024 | 15.10 | Hematologic | Lymphocyte | 2,286 | 3 | 18 | 34 | |
| 142 | Fracture fixation | MSKEL000047 | 15.02 | Musculoskeletal | B / plasma cell | 0 | 2 | 9 | 16 | |
| 143 | Cancer, Testis | MALIG000031 | 15.02 | Malignancy | B / plasma cell | 0 | 0 | 1 | 7 | |
| 144 | CALCOCO1/TBC1D5 ratio | PRORT000302 | 15.00 | Protein ratios | Neural / glial | 0 | 3 | 16 | 33 | |
| 145 | LGALS4 levels | PROLV001204 | 14.95 | Protein levels | B / plasma cell | 26 | 1 | 9 | 12 | |
| 146 | ABL1/DNMBP ratio | PRORT000009 | 14.91 | Protein ratios | Hepatocyte | 1 | 1 | 9 | 21 | |
| 147 | CD27/DLL1 ratio | PRORT000412 | 14.90 | Protein ratios | B / plasma cell | 15 | 3 | 9 | 19 | |
| 148 | CRTAM/LY9 ratio | PRORT000772 | 14.63 | Protein ratios | Lymphocyte | 31 | 3 | 16 | 28 | |
| 149 | CHIT1 levels | PROLV000429 | 14.53 | Protein levels | Myeloid | 45 | 3 | 9 | 16 | |
| 150 | CD302/IL12A_IL12B ratio | PRORT000438 | 14.53 | Protein ratios | B / plasma cell | 43 | 4 | 9 | 19 | |
| 151 | CRTAM/ICAM3 ratio | PRORT000770 | 14.32 | Protein ratios | Lymphocyte | 23 | 2 | 20 | 46 | |
| 152 | Occupational attainment | SOCIO000007 | 14.25 | Socioeconomic | Myeloid | 6 | 5 | 7 | 20 | |
| 153 | IBD-Ulcerative colitis, with PSC | IMMUN000016 | 14.23 | Immunologic | Myeloid | 38 | 5 | 13 | 25 | |
| 154 | BSG/IL12A_IL12B ratio | PRORT000247 | 14.23 | Protein ratios | B / plasma cell | 54 | 3 | 7 | 14 | |
| 155 | CTSO levels | PROLV000567 | 14.22 | Protein levels | Myeloid | 112 | 2 | 11 | 27 | |
| 156 | AIDA levels | PROLV000067 | 14.17 | Protein levels | B / plasma cell | — | 2 | 5 | 25 | |
| 157 | FCER1A levels | PROLV000776 | 14.15 | Protein levels | Myeloid | 18 | 3 | 21 | 40 | |
| 158 | Medication, dermatologic | DERMA000024 | 14.10 | Dermatologic | Lymphocyte | 18 | 2 | 18 | 21 | |
| 159 | POMC levels | PROLV001599 | 13.85 | Protein levels | B / plasma cell | 28 | 1 | 3 | 12 | |
| 160 | CD74 levels | PROLV000355 | 13.85 | Protein levels | B / plasma cell | 145 | 2 | 9 | 18 | |
| 161 | Degenerative skin disorder | DERMA000038 | 13.80 | Dermatologic | Lymphocyte | 127 | 3 | 13 | 22 | |
| 162 | KDM3A levels | PROLV001132 | 13.75 | Protein levels | Lymphocyte | 21 | 2 | 16 | 40 | |
| 163 | Rheumatoid arthritis, RA | IMMUN000019 | 13.67 | Immunologic | Lymphocyte | 250 | 2 | 16 | 11 | |
| 164 | CLEC4G levels | PROLV000453 | 13.66 | Protein levels | Myeloid | 82 | 3 | 10 | 17 | |
| 165 | ST13 levels | PROLV001951 | 13.54 | Protein levels | Lymphocyte | 2 | 5 | 15 | 39 | |
| 166 | FOLR2 levels | PROLV000823 | 13.52 | Protein levels | Myeloid | 134 | 3 | 10 | 11 | |
| 167 | LRRC37A2 levels | PROLV001233 | 13.48 | Protein levels | B / plasma cell | 17 | 2 | 13 | 27 | |
| 168 | ARTN levels | PROLV000148 | 13.41 | Protein levels | Myeloid | 0 | 3 | 10 | 18 | |
| 169 | CD79B/CKAP4 ratio | PRORT000509 | 13.36 | Protein ratios | B / plasma cell | 35 | 2 | 8 | 8 | |
| 170 | CD27/CD79B ratio | PRORT000411 | 13.28 | Protein ratios | B / plasma cell | 12 | 3 | 15 | 22 | |
| 171 | EIF3J levels | PROLV000694 | 13.27 | Protein levels | Neural / glial | 0 | 3 | 6 | 12 | |
| 172 | ERBB4/F3 ratio | PRORT001046 | 13.25 | Protein ratios | B / plasma cell | 8 | 2 | 8 | 28 | |
| 173 | Neurofibromatosis | NEURO000024 | 13.24 | Neurologic | Lymphocyte | 0 | 3 | 13 | 23 | |
| 174 | Orbital disorder | OPHTH000021 | 13.21 | Ophthalmic | Lymphocyte | 47 | 3 | 15 | 38 | |
| 175 | Multiple sclerosis | IMMUN000034 | 13.11 | Immunologic | Lymphocyte | 56 | 2 | 16 | 23 | |
| 176 | REG3A levels | PROLV001719 | 13.04 | Protein levels | B / plasma cell | 29 | 1 | 8 | 10 | |
| 177 | Mental disorder | PSYCH000013 | 13.01 | Psychiatric | Neural / glial | 21 | 2 | 9 | 20 | |
| 178 | GFRA2/IL12A_IL12B ratio | PRORT001210 | 12.99 | Protein ratios | B / plasma cell | 52 | 3 | 12 | 22 | |
| 179 | Drug hypersensitivity | IMMUN000006 | 12.89 | Immunologic | Lymphocyte | 23 | 4 | 14 | 32 | |
| 180 | Medication, thyroid | ENDOC000002 | 12.88 | Endocrine | Lymphocyte | 202 | 1 | 13 | 19 | |
| 181 | CALCOCO1/IRAG2 ratio | PRORT000297 | 12.86 | Protein ratios | Neural / glial | 0 | 2 | 18 | 34 | |
| 182 | CA3/HMBS ratio | PRORT000280 | 12.85 | Protein ratios | B / plasma cell | 12 | 4 | 15 | 37 | |
| 183 | TNFRSF14/TNFSF14 ratio | PRORT001851 | 12.78 | Protein ratios | Hepatocyte | 14 | 3 | 15 | 47 | |
| 184 | CEACAM8/MMP9 ratio | PRORT000587 | 12.76 | Protein ratios | Myeloid | 32 | 2 | 9 | 12 | |
| 185 | CDKN2D/TACC3 ratio | PRORT000580 | 12.69 | Protein ratios | Hematopoietic progenitor | 1 | 4 | 11 | 29 | |
| 186 | LILRB2 levels | PROLV001214 | 12.62 | Protein levels | Myeloid | 128 | 4 | 13 | 17 | |
| 187 | DEFA1_DEFA1B/LCN2 ratio | PRORT000885 | 12.50 | Protein ratios | Myeloid | 58 | 4 | 9 | 16 | |
| 188 | B2M levels | PROLV000169 | 12.43 | Protein levels | Lymphocyte | 54 | 3 | 16 | 24 | |
| 189 | TYRP1 levels | PROLV002130 | 12.35 | Protein levels | Myeloid | 94 | 5 | 11 | 17 | |
| 190 | EPHB6/VWC2 ratio | PRORT001039 | 12.32 | Protein ratios | B / plasma cell | 2 | 4 | 11 | 20 | |
| 191 | Household composition | SOCIO000010 | 12.09 | Socioeconomic | Neural / glial | 0 | 4 | 14 | 29 | |
| 192 | SFTPA1 levels | PROLV001847 | 12.08 | Protein levels | B / plasma cell | 0 | 0 | 3 | 9 | |
| 193 | CDKN1A/TACC3 ratio | PRORT000572 | 12.07 | Protein ratios | B / plasma cell | 20 | 4 | 12 | 29 | |
| 194 | CD38/IL12A_IL12B ratio | PRORT000439 | 12.02 | Protein ratios | Myeloid | 70 | 3 | 7 | 11 | |
| 195 | SPINT1/SUSD2 ratio | PRORT001810 | 11.98 | Protein ratios | B / plasma cell | 20 | 1 | 6 | 7 | |
| 196 | Benign neoplasm, Endocrine | MALIG000003 | 11.96 | Malignancy | Myeloid | 1 | 3 | 9 | 18 | |
| 197 | ELOA/POLR2F ratio | PRORT001016 | 11.93 | Protein ratios | Muscle / cardiac | 0 | 3 | 16 | 28 | |
| 198 | PDCD1/TNFRSF9 ratio | PRORT001631 | 11.92 | Protein ratios | Epithelial | 7 | 1 | 13 | 21 | |
| 199 | Polyglandular dysfunction | IMMUN000037 | 11.87 | Immunologic | B / plasma cell | 0 | 3 | 10 | 21 | |
| 200 | SNX2 levels | PROLV001913 | 11.85 | Protein levels | B / plasma cell | 8 | 1 | 6 | 17 | |
| 201 | ADH4/SCLY ratio | PRORT000043 | 11.82 | Protein ratios | Hepatocyte | 18 | 4 | 15 | 30 | |
| 202 | Sjogren syndrome | IMMUN000043 | 11.79 | Immunologic | Lymphocyte | 33 | 2 | 11 | 18 | |
| 203 | C1R levels | PROLV000227 | 11.74 | Protein levels | Hepatocyte | 0 | 4 | 15 | 29 | |
| 204 | IL16 levels | PROLV001050 | 11.65 | Protein levels | Muscle / cardiac | 38 | 2 | 7 | 27 | |
| 205 | Maximal oxygen uptake | CARDI000026 | 11.54 | Cardiac | B / plasma cell | 1 | 4 | 12 | 22 | |
| 206 | Medication, alcohol use disorder | PSYCH000018 | 11.48 | Psychiatric | B / plasma cell | 0 | 5 | 12 | 15 | |
| 207 | IPCEF1/TBCC ratio | PRORT001365 | 11.46 | Protein ratios | B / plasma cell | 1 | 1 | 11 | 17 | |
| 208 | SEPTIN8 levels | PROLV001814 | 11.42 | Protein levels | B / plasma cell | 0 | 2 | 8 | 24 | |
| 209 | Stressful life events | PSYCH000053 | 11.42 | Psychiatric | Neural / glial | 0 | 5 | 9 | 21 | |
| 210 | LGALS8/SOD2 ratio | PRORT001453 | 11.42 | Protein ratios | Myeloid | 6 | 6 | 16 | 28 | |
| 211 | Physical activity, none | BEHAV000005 | 11.31 | Behavioural | Myeloid | 0 | 4 | 15 | 23 | |
| 212 | QPCT levels | PROLV001693 | 11.21 | Protein levels | Lymphocyte | 72 | 3 | 9 | 24 | |
| 213 | SNX15 levels | PROLV001911 | 11.20 | Protein levels | Lymphocyte | 12 | 5 | 20 | 50 | |
| 214 | Total protein levels | PROLV002131 | 11.18 | Protein levels | Myeloid | 897 | 4 | 12 | 26 | |
| 215 | MAPRE3 levels | PROLV001273 | 11.11 | Protein levels | Lymphocyte | 67 | 3 | 16 | 32 | |
| 216 | RCC1 levels | PROLV001715 | 11.05 | Protein levels | B / plasma cell | 14 | 2 | 8 | 21 | |
| 217 | NME3 levels | PROLV001409 | 11.04 | Protein levels | Myeloid | 92 | 4 | 15 | 35 | |
| 218 | White blood cell disorder | HEMAT000019 | 11.01 | Hematologic | Lymphocyte | 2 | 3 | 10 | 35 | |
| 219 | ADD1 levels | PROLV000039 | 10.95 | Protein levels | Lymphocyte | 1 | 1 | 9 | 31 | |
| 220 | PAM levels | PROLV001492 | 10.92 | Protein levels | Myeloid | 112 | 2 | 11 | 21 | |
| 221 | CD40/IGSF8 ratio | PRORT000444 | 10.88 | Protein ratios | Muscle / cardiac | 5 | 6 | 9 | 20 | |
| 222 | IL12A_IL12B/LAG3 ratio | PRORT001341 | 10.83 | Protein ratios | B / plasma cell | 67 | 3 | 7 | 9 | |
| 223 | ARL13B levels | PROLV000143 | 10.82 | Protein levels | Stromal / connective | 0 | 1 | 5 | 10 | |
| 224 | NOTCH1/SEMA7A ratio | PRORT001591 | 10.79 | Protein ratios | B / plasma cell | 20 | 2 | 11 | 15 | |
| 225 | CFHR2 levels | PROLV000415 | 10.76 | Protein levels | Myeloid | 27 | 4 | 9 | 12 | |
| 226 | RAP1A levels | PROLV001704 | 10.69 | Protein levels | Lymphocyte | 15 | 2 | 12 | 20 | |
| 227 | CILP levels | PROLV000436 | 10.66 | Protein levels | Myeloid | 47 | 5 | 12 | 21 | |
| 228 | CD79B levels | PROLV000356 | 10.65 | Protein levels | B / plasma cell | 22 | 1 | 6 | 5 | |
| 229 | CD48 levels | PROLV000343 | 10.62 | Protein levels | B / plasma cell | 92 | 2 | 8 | 19 | |
| 230 | PECAM1/SOD2 ratio | PRORT001662 | 10.57 | Protein ratios | Myeloid | 17 | 5 | 13 | 18 | |
| 231 | MAMDC4 levels | PROLV001259 | 10.56 | Protein levels | Hepatocyte | 46 | 2 | 7 | 11 | |
| 232 | ADGRE2 levels | PROLV000043 | 10.50 | Protein levels | Myeloid | 136 | 3 | 10 | 22 | |
| 233 | Urticaria | IMMUN000007 | 10.46 | Immunologic | Myeloid | 26 | 0 | 0 | 5 | |
| 234 | FOXO1/MAP4K5 ratio | PRORT001173 | 10.42 | Protein ratios | Lymphocyte | 0 | 3 | 12 | 41 | |
| 235 | ADM levels | PROLV000051 | 10.37 | Protein levels | B / plasma cell | 52 | 1 | 6 | 13 | |
| 236 | PDGFRB levels | PROLV001526 | 10.37 | Protein levels | Myeloid | 59 | 6 | 15 | 28 | |
| 237 | CCL17/PDGFB ratio | PRORT000346 | 10.31 | Protein ratios | Lymphocyte | 23 | 3 | 17 | 37 | |
| 238 | Osteochondrodysplasia | MSKEL000054 | 10.27 | Musculoskeletal | B / plasma cell | 0 | 2 | 8 | 18 | |
| 239 | IL12A or IL12B levels | PROLV001044 | 10.25 | Protein levels | Myeloid | 210 | 4 | 10 | 21 | |
| 240 | PTPN1/WWP2 ratio | PRORT001718 | 10.25 | Protein ratios | Muscle / cardiac | 12 | 2 | 14 | 27 | |
| 241 | Syncope | NEURO000025 | 10.20 | Neurologic | B / plasma cell | 0 | 1 | 6 | 10 | |
| 242 | CD84/TREML2 ratio | PRORT000529 | 10.14 | Protein ratios | B / plasma cell | 3 | 2 | 4 | 10 | |
| 243 | C1QTNF1/COL18A1 ratio | PRORT000262 | 10.12 | Protein ratios | B / plasma cell | 6 | 3 | 8 | 18 | |
| 244 | Schizophrenia | PSYCH000036 | 10.08 | Psychiatric | Neural / glial | 9 | 5 | 12 | 23 | |
| 245 | Allergic conjunctivitis | IMMUN000002 | 10.08 | Immunologic | Lymphocyte | 34 | 2 | 8 | 28 | |
| 246 | S100P levels | PROLV001773 | 10.02 | Protein levels | Myeloid | 20 | 4 | 10 | 14 | |
| 247 | Medication, insulin therapy | METBL000027 | 9.99 | Metabolic | Hematopoietic progenitor | 22 | 1 | 5 | 11 | |
| 248 | LSP1 levels | PROLV001238 | 9.94 | Protein levels | Neural / glial | 14 | 6 | 14 | 47 | |
| 249 | Cervicobrachial syndrome | MSKEL000073 | 9.91 | Musculoskeletal | Muscle / cardiac | 0 | 3 | 8 | 15 | |
| 250 | PRTG levels | PROLV001650 | 9.89 | Protein levels | Hepatocyte | 34 | 4 | 11 | 17 | |
| 251 | PFKM levels | PROLV001541 | 9.77 | Protein levels | Lymphocyte | 0 | 3 | 15 | 30 | |
| 252 | TNFRSF9 levels | PROLV002074 | 9.72 | Protein levels | B / plasma cell | 81 | 1 | 15 | 24 | |
| 253 | CD5/TNFRSF9 ratio | PRORT000468 | 9.72 | Protein ratios | Lymphocyte | 46 | 2 | 16 | 41 | |
| 254 | Influenza | IMMUN000065 | 9.67 | Immunologic | B / plasma cell | 21 | 3 | 6 | 11 | |
| 255 | Thyroid peroxidase antibodies | IMMUN000045 | 9.64 | Immunologic | Lymphocyte | 20 | 2 | 14 | 22 | |
| 256 | CNTNAP4 levels | PROLV000481 | 9.57 | Protein levels | Lymphocyte | 38 | 0 | 7 | 16 | |
| 257 | FAM151A levels | PROLV000760 | 9.57 | Protein levels | Neural / glial | 0 | 5 | 9 | 15 | |
| 258 | SEMA4C levels | PROLV001809 | 9.54 | Protein levels | Hepatocyte | 20 | 4 | 17 | 38 | |
| 259 | NFATC3 levels | PROLV001396 | 9.50 | Protein levels | B / plasma cell | 57 | 3 | 10 | 17 | |
| 260 | TCN2 levels | PROLV002004 | 9.48 | Protein levels | Myeloid | 63 | 2 | 8 | 12 | |
| 261 | Family history, skin cancer | MALIG000040 | 9.47 | Malignancy | B / plasma cell | 8 | 0 | 3 | 9 | |
| 262 | ADGRE5/VCAM1 ratio | PRORT000034 | 9.42 | Protein ratios | Myeloid | 37 | 4 | 11 | 18 | |
| 263 | Lactase deficiency | METBL000002 | 9.39 | Metabolic | Vascular | 0 | 2 | 5 | 12 | |
| 264 | TNFRSF8/TNFRSF9 ratio | PRORT001855 | 9.38 | Protein ratios | Myeloid | 3 | 4 | 12 | 23 | |
| 265 | LYN/TACC3 ratio | PRORT001473 | 9.35 | Protein ratios | B / plasma cell | 0 | 6 | 9 | 16 | |
| 266 | Spleen volume | HEMAT000042 | 9.33 | Hematologic | B / plasma cell | 17 | 4 | 8 | 13 | |
| 267 | RTBDN levels | PROLV001760 | 9.27 | Protein levels | B / plasma cell | 12 | 1 | 6 | 12 | |
| 268 | CD160/NCR1 ratio | PRORT000378 | 9.25 | Protein ratios | Lymphocyte | 58 | 2 | 12 | 27 | |
| 269 | EZR levels | PROLV000739 | 9.24 | Protein levels | Myeloid | 46 | 3 | 15 | 27 | |
| 270 | CTSC levels | PROLV000561 | 9.22 | Protein levels | Hepatocyte | 71 | 3 | 13 | 17 | |
| 271 | CHI3L1/PRSS8 ratio | PRORT000611 | 9.16 | Protein ratios | Myeloid | 7 | 5 | 11 | 23 | |
| 272 | C1QL2 levels | PROLV000223 | 9.14 | Protein levels | Vascular | 43 | 2 | 7 | 24 | |
| 273 | CDHR1 levels | PROLV000378 | 9.12 | Protein levels | Muscle / cardiac | 0 | 4 | 11 | 24 | |
| 274 | Hypothyroidism, autoimmune | IMMUN000015 | 9.09 | Immunologic | Lymphocyte | 218 | 2 | 11 | 15 | |
| 275 | CCL5/SELP ratio | PRORT000358 | 9.09 | Protein ratios | Lymphocyte | 2 | 1 | 6 | 32 | |
| 276 | ADAM23 levels | PROLV000028 | 9.03 | Protein levels | Granulosa cell | 35 | 1 | 4 | 4 | |
| 277 | CNTNAP2 levels | PROLV000480 | 9.02 | Protein levels | Myeloid | 28 | 2 | 10 | 16 | |
| 278 | Retirement wellbeing | SOCIO000027 | 9.02 | Socioeconomic | Neural / glial | 1 | 5 | 6 | 12 | |
| 279 | Cough | RESPI000027 | 9.01 | Respiratory | Myeloid | 0 | 4 | 7 | 11 | |
| 280 | ANPEP/CXADR ratio | PRORT000100 | 8.97 | Protein ratios | Vascular | 11 | 3 | 12 | 10 | |
| 281 | Drug poisoning | MISCL000036 | 8.97 | Miscellaneous | Lymphocyte | 11 | 4 | 17 | 34 | |
| 282 | EFNA4/TNFRSF9 ratio | PRORT000992 | 8.96 | Protein ratios | B / plasma cell | 16 | 3 | 18 | 25 | |
| 283 | CABP2 levels | PROLV000249 | 8.93 | Protein levels | B / plasma cell | 21 | 2 | 4 | 10 | |
| 284 | AFP levels | PROLV000053 | 8.93 | Protein levels | Hepatocyte | 177 | 1 | 5 | 7 | |
| 285 | Lipid unsaturation | LIPID000079 | 8.89 | Lipids | Lymphocyte | 10 | 1 | 13 | 40 | |
| 286 | ICAM3/LY9 ratio | PRORT001326 | 8.89 | Protein ratios | B / plasma cell | 36 | 3 | 13 | 42 | |
| 287 | SKAP1 levels | PROLV001872 | 8.88 | Protein levels | Lymphocyte | 90 | 2 | 11 | 18 | |
| 288 | Dizziness and giddiness | AUDIO000020 | 8.87 | Auditory | Neural / glial | 0 | 4 | 14 | 32 | |
| 289 | CCDC50 levels | PROLV000275 | 8.85 | Protein levels | B / plasma cell | 0 | 4 | 7 | 12 | |
| 290 | PDGFA/USP8 ratio | PRORT001638 | 8.84 | Protein ratios | Myeloid | 3 | 4 | 16 | 26 | |
| 291 | POSTN levels | PROLV001603 | 8.81 | Protein levels | Adipose | 40 | 1 | 5 | 14 | |
| 292 | Chalazion | OPHTH000017 | 8.81 | Ophthalmic | Lymphocyte | 12 | 2 | 19 | 45 | |
| 293 | MGAT2 levels | PROLV001308 | 8.78 | Protein levels | Neural / glial | 2 | 4 | 11 | 21 | |
| 294 | Atrioventricular block | CARDI000028 | 8.75 | Cardiac | Muscle / cardiac | 7 | 4 | 6 | 19 | |
| 295 | CD164/CD99 ratio | PRORT000386 | 8.74 | Protein ratios | Myeloid | 8 | 4 | 7 | 14 | |
| 296 | Pulmonary fibrosis | RESPI000017 | 8.73 | Respiratory | Lymphocyte | 5 | 2 | 12 | 33 | |
| 297 | SEMA7A levels | PROLV001811 | 8.73 | Protein levels | Myeloid | 113 | 2 | 11 | 23 | |
| 298 | Medication, hypnotic or sedative | PSYCH000020 | 8.73 | Psychiatric | Neural / glial | 1 | 5 | 14 | 26 | |
| 299 | Phosphatidylserines | LIPID000062 | 8.71 | Lipids | B / plasma cell | 0 | 0 | 5 | 17 | |
| 300 | UCMA levels | PROLV002135 | 8.70 | Protein levels | Lymphocyte | 0 | 5 | 11 | 34 | |
| 301 | Educational attainment | SOCIO000002 | 8.66 | Socioeconomic | Neural / glial | 143 | 5 | 11 | 23 | |
| 302 | Social trust | SOCIO000023 | 8.66 | Socioeconomic | Stromal / connective | 0 | 5 | 12 | 19 | |
| 303 | CXCL5/PLXNA4 ratio | PRORT000829 | 8.63 | Protein ratios | Myeloid | 0 | 5 | 14 | 31 | |
| 304 | ACY1/SCLY ratio | PRORT000021 | 8.54 | Protein ratios | Hepatocyte | 6 | 3 | 12 | 17 | |
| 305 | VAMP5 levels | PROLV002148 | 8.51 | Protein levels | Hepatocyte | 9 | 3 | 10 | 18 | |
| 306 | GOLM2/ITGA5 ratio | PRORT001222 | 8.50 | Protein ratios | Myeloid | 32 | 5 | 14 | 32 | |
| 307 | Ocular refraction | OPHTH000033 | 8.45 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 308 | CLEC4C levels | PROLV000451 | 8.45 | Protein levels | Myeloid | 124 | 4 | 9 | 15 | |
| 309 | CD244/CRTAM ratio | PRORT000406 | 8.42 | Protein ratios | Lymphocyte | 30 | 2 | 14 | 25 | |
| 310 | Erythematosquamous dermatosis | DERMA000009 | 8.42 | Dermatologic | Lymphocyte | 92 | 2 | 19 | 20 | |
| 311 | PADI2 levels | PROLV001483 | 8.38 | Protein levels | B / plasma cell | 4 | 1 | 3 | 8 | |
| 312 | TDRKH/TST ratio | PRORT001830 | 8.35 | Protein ratios | Myeloid | 11 | 6 | 16 | 28 | |
| 313 | THBS2 levels | PROLV002026 | 8.34 | Protein levels | Lymphocyte | 30 | 2 | 11 | 39 | |
| 314 | ATP5IF1/FXN ratio | PRORT000157 | 8.33 | Protein ratios | Hepatocyte | 7 | 4 | 12 | 21 | |
| 315 | Estradiol | ENDOC000006 | 8.33 | Endocrine | Hepatocyte | 16 | 3 | 9 | 17 | |
| 316 | Medication, antispasmodic | GASTR000015 | 8.32 | Gastrointestinal | Lymphocyte | 0 | 3 | 9 | 27 | |
| 317 | ZP3 levels | PROLV002215 | 8.29 | Protein levels | B / plasma cell | 28 | 1 | 6 | 17 | |
| 318 | CSNK1D levels | PROLV000542 | 8.29 | Protein levels | Lymphocyte | 32 | 2 | 12 | 32 | |
| 319 | SLAMF7 levels | PROLV001876 | 8.27 | Protein levels | Myeloid | 126 | 3 | 7 | 14 | |
| 320 | DCTN6/TDRKH ratio | PRORT000875 | 8.27 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 31 | |
| 321 | Latent factor, neutrophil and lymphocyte | HEMAT000035 | 8.24 | Hematologic | Myeloid | 675 | 4 | 18 | 31 | |
| 322 | CD48/CRTAM ratio | PRORT000463 | 8.23 | Protein ratios | Lymphocyte | 45 | 2 | 15 | 25 | |
| 323 | GABBR2 levels | PROLV000845 | 8.22 | Protein levels | B / plasma cell | 0 | 2 | 4 | 9 | |
| 324 | DAB2/FKBP1B ratio | PRORT000836 | 8.22 | Protein ratios | Muscle / cardiac | 0 | 4 | 12 | 37 | |
| 325 | MGLL/MITD1 ratio | PRORT001527 | 8.20 | Protein ratios | Hepatocyte | 42 | 3 | 11 | 16 | |
| 326 | LGALS3BP levels | PROLV001203 | 8.20 | Protein levels | Myeloid | 120 | 3 | 12 | 16 | |
| 327 | Reimbursement for rheumatic disease | IMMUN000042 | 8.17 | Immunologic | Lymphocyte | 112 | 2 | 16 | 16 | |
| 328 | ARHGAP30 levels | PROLV000137 | 8.17 | Protein levels | Lymphocyte | 10 | 3 | 12 | 40 | |
| 329 | Myasthenia gravis | IMMUN000035 | 8.15 | Immunologic | Lymphocyte | 54 | 1 | 13 | 36 | |
| 330 | FABP1/SULT2A1 ratio | PRORT001097 | 8.11 | Protein ratios | Hepatocyte | 10 | 4 | 8 | 18 | |
| 331 | AXIN1/SRPK2 ratio | PRORT000177 | 8.09 | Protein ratios | Hepatocyte | 0 | 3 | 12 | 38 | |
| 332 | Hyperthyroidism, autoimmune | IMMUN000014 | 8.08 | Immunologic | Lymphocyte | 60 | 2 | 13 | 28 | |
| 333 | Meat preference | DTSUP000015 | 8.04 | Diet and Supplement | Neural / glial | 47 | 5 | 12 | 14 | |
| 334 | CAPN3 levels | PROLV000263 | 8.04 | Protein levels | B / plasma cell | 0 | 2 | 9 | 11 | |
| 335 | Nephrotic syndrome | NEPHR000011 | 8.01 | Nephrourologic | B / plasma cell | — | 3 | 8 | 28 | |
| 336 | Autoimmune disease | IMMUN000023 | 7.95 | Immunologic | Lymphocyte | 287 | 2 | 12 | 15 | |
| 337 | GZMA/LTA ratio | PRORT001260 | 7.94 | Protein ratios | Lymphocyte | 33 | 3 | 11 | 34 | |
| 338 | Gut microbial abundance, Rubneribacter | GASTR000035 | 7.93 | Gastrointestinal | Neural / glial | 0 | 2 | 10 | 19 | |
| 339 | CD22/CD79B ratio | PRORT000399 | 7.91 | Protein ratios | B / plasma cell | 16 | 1 | 7 | 10 | |
| 340 | SERPINE1/USP8 ratio | PRORT001779 | 7.89 | Protein ratios | Lymphocyte | 0 | 4 | 16 | 40 | |
| 341 | Latent factor, white cell | HEMAT000039 | 7.88 | Hematologic | Myeloid | 183 | 2 | 4 | 24 | |
| 342 | DRAXIN levels | PROLV000651 | 7.84 | Protein levels | B / plasma cell | 29 | 2 | 7 | 16 | |
| 343 | ADGRE5/SEMA7A ratio | PRORT000033 | 7.77 | Protein ratios | Myeloid | 18 | 2 | 6 | 13 | |
| 344 | CRYGD levels | PROLV000534 | 7.74 | Protein levels | Hematopoietic progenitor | 17 | 1 | 5 | 20 | |
| 345 | Corrective lens use | OPHTH000032 | 7.73 | Ophthalmic | Neural / glial | 66 | 8 | 14 | 25 | |
| 346 | TNFRSF6B levels | PROLV002072 | 7.73 | Protein levels | B / plasma cell | 32 | 2 | 8 | 11 | |
| 347 | Skin sebum | DERMA000036 | 7.70 | Dermatologic | Stromal / connective | 0 | 2 | 6 | 12 | |
| 348 | IBD-Inflammatory bowel disease | IMMUN000030 | 7.70 | Immunologic | Lymphocyte | 230 | 4 | 19 | 29 | |
| 349 | ATOX1/TMSB10 ratio | PRORT000153 | 7.69 | Protein ratios | Myeloid | 4 | 3 | 9 | 17 | |
| 350 | PADI4 levels | PROLV001484 | 7.68 | Protein levels | B / plasma cell | 1 | 4 | 15 | 26 | |
| 351 | Graves disease | IMMUN000027 | 7.67 | Immunologic | Lymphocyte | 94 | 1 | 11 | 18 | |
| 352 | MANSC1/PODXL2 ratio | PRORT001484 | 7.66 | Protein ratios | Hepatocyte | 3 | 2 | 10 | 22 | |
| 353 | MAP3K5/MAVS ratio | PRORT001488 | 7.64 | Protein ratios | B / plasma cell | 7 | 3 | 12 | 15 | |
| 354 | CD200/CLEC4G ratio | PRORT000392 | 7.64 | Protein ratios | Granulosa cell | 34 | 3 | 10 | 20 | |
| 355 | TNFRSF4/TNFRSF8 ratio | PRORT001853 | 7.64 | Protein ratios | Vascular | 2 | 2 | 6 | 10 | |
| 356 | Cancer, Urinary tract | MALIG000033 | 7.63 | Malignancy | Lymphocyte | 4 | 1 | 13 | 11 | |
| 357 | IRAG2/TBC1D23 ratio | PRORT001367 | 7.60 | Protein ratios | Hepatocyte | 1 | 2 | 9 | 19 | |
| 358 | IFI30 levels | PROLV001014 | 7.58 | Protein levels | Myeloid | 93 | 4 | 19 | 45 | |
| 359 | COL9A1 levels | PROLV000493 | 7.56 | Protein levels | Stromal / connective | 7 | 6 | 17 | 22 | |
| 360 | LTA levels | PROLV001239 | 7.55 | Protein levels | Lymphocyte | 112 | 3 | 17 | 32 | |
| 361 | Ventricular wall thickness | CARDI000016 | 7.55 | Cardiac | Muscle / cardiac | 47 | 2 | 3 | 11 | |
| 362 | BAG6/BMP6 ratio | PRORT000200 | 7.55 | Protein ratios | Hepatocyte | 21 | 3 | 12 | 38 | |
| 363 | CEP43/USP8 ratio | PRORT000602 | 7.53 | Protein ratios | Myeloid | 0 | 2 | 8 | 27 | |
| 364 | CEACAM8 levels | PROLV000394 | 7.53 | Protein levels | Myeloid | 75 | 2 | 11 | 14 | |
| 365 | LCN2/PGLYRP1 ratio | PRORT001441 | 7.51 | Protein ratios | Lymphocyte | 75 | 3 | 16 | 48 | |
| 366 | Physical activity | BEHAV000007 | 7.51 | Behavioural | Neural / glial | 105 | 3 | 7 | 24 | |
| 367 | Hypothyroidism | ENDOC000021 | 7.51 | Endocrine | Lymphocyte | 371 | 1 | 12 | 20 | |
| 368 | GDI2 levels | PROLV000871 | 7.43 | Protein levels | Hepatocyte | 0 | 4 | 12 | 35 | |
| 369 | CCL3 levels | PROLV000296 | 7.42 | Protein levels | Myeloid | 77 | 3 | 9 | 19 | |
| 370 | Tonsillar and adenoidal disorders | RESPI000040 | 7.41 | Respiratory | Myeloid | 125 | 2 | 10 | 27 | |
| 371 | PLXNB2/SEMA7A ratio | PRORT001690 | 7.38 | Protein ratios | B / plasma cell | 8 | 2 | 8 | 21 | |
| 372 | Cereal preference | DTSUP000010 | 7.37 | Diet and Supplement | Neural / glial | 29 | 5 | 9 | 20 | |
| 373 | CCS levels | PROLV000307 | 7.35 | Protein levels | Lymphocyte | 50 | 2 | 13 | 44 | |
| 374 | FABP1 levels | PROLV000751 | 7.34 | Protein levels | Neural / glial | 0 | 2 | 9 | 16 | |
| 375 | DNAJB2 levels | PROLV000632 | 7.34 | Protein levels | Lymphocyte | 19 | 4 | 17 | 45 | |
| 376 | CD48/FCRL6 ratio | PRORT000464 | 7.30 | Protein ratios | Lymphocyte | 25 | 2 | 12 | 34 | |
| 377 | Medical conditions, allergy etc, none | MISCL000026 | 7.30 | Miscellaneous | Lymphocyte | 251 | 2 | 12 | 15 | |
| 378 | Supplement use, mineral or vitamin, none | DTSUP000027 | 7.29 | Diet and Supplement | Neural / glial | 2 | 5 | 8 | 19 | |
| 379 | Occupation | SOCIO000006 | 7.27 | Socioeconomic | Neural / glial | 1 | 1 | 4 | 6 | |
| 380 | Financial satisfaction | SOCIO000024 | 7.27 | Socioeconomic | Neural / glial | 0 | 2 | 8 | 18 | |
| 381 | Endocrine gland disorder | ENDOC000003 | 7.25 | Endocrine | Neural / glial | 0 | 3 | 5 | 13 | |
| 382 | Enthesopathy | MSKEL000061 | 7.25 | Musculoskeletal | Lymphocyte | 0 | 0 | 1 | 11 | |
| 383 | LRIG3 levels | PROLV001228 | 7.23 | Protein levels | Lymphocyte | 0 | 0 | 9 | 20 | |
| 384 | RASSF2 levels | PROLV001707 | 7.21 | Protein levels | Muscle / cardiac | 5 | 5 | 12 | 26 | |
| 385 | GALNT5 levels | PROLV000851 | 7.20 | Protein levels | Hematopoietic progenitor | 44 | 4 | 7 | 15 | |
| 386 | Psoriasis | IMMUN000039 | 7.19 | Immunologic | Lymphocyte | 213 | 2 | 14 | 19 | |
| 387 | Infant mortality rate | MISCL000003 | 7.19 | Miscellaneous | Myeloid | 1 | 3 | 10 | 20 | |
| 388 | CD27/FCRL5 ratio | PRORT000413 | 7.17 | Protein ratios | Neural / glial | 71 | 6 | 14 | 27 | |
| 389 | BIN1 levels | PROLV000196 | 7.16 | Protein levels | Muscle / cardiac | 0 | 2 | 10 | 18 | |
| 390 | Arginine metabolites | METAB000003 | 7.14 | Metabolites | B / plasma cell | 3 | 0 | 1 | 2 | |
| 391 | VEGFB levels | PROLV002158 | 7.08 | Protein levels | Lymphocyte | 54 | 3 | 14 | 35 | |
| 392 | Dissociative disorder | PSYCH000012 | 7.08 | Psychiatric | Lymphocyte | 0 | 2 | 14 | 19 | |
| 393 | GFRA2 levels | PROLV000877 | 7.07 | Protein levels | Myeloid | 66 | 3 | 18 | 20 | |
| 394 | ARHGAP25/RNF41 ratio | PRORT000139 | 7.05 | Protein ratios | Lymphocyte | 0 | 4 | 13 | 28 | |
| 395 | EFNA4 levels | PROLV000682 | 7.05 | Protein levels | Lymphocyte | 16 | 1 | 9 | 21 | |
| 396 | SIT1 levels | PROLV001871 | 7.05 | Protein levels | Lymphocyte | 69 | 2 | 16 | 32 | |
| 397 | Thyrotoxicosis | ENDOC000024 | 7.04 | Endocrine | Lymphocyte | 91 | 1 | 11 | 19 | |
| 398 | ADH4/CA5A ratio | PRORT000038 | 7.02 | Protein ratios | Hepatocyte | 30 | 2 | 14 | 26 | |
| 399 | KLRB1 levels | PROLV001161 | 7.00 | Protein levels | Lymphocyte | 88 | 2 | 17 | 26 | |
| 400 | CHRDL1 levels | PROLV000433 | 6.99 | Protein levels | B / plasma cell | 1 | 2 | 4 | 9 | |
| 401 | NPC2 levels | PROLV001419 | 6.98 | Protein levels | Myeloid | 24 | 1 | 5 | 9 | |
| 402 | GALNT10/SEMA7A ratio | PRORT001202 | 6.97 | Protein ratios | Lymphocyte | 3 | 2 | 11 | 33 | |
| 403 | PPP1R2/USP8 ratio | PRORT001708 | 6.96 | Protein ratios | Hepatocyte | 13 | 3 | 9 | 21 | |
| 404 | Disability allowance | SOCIO000019 | 6.95 | Socioeconomic | Neural / glial | 0 | 4 | 15 | 28 | |
| 405 | ENPP5 levels | PROLV000709 | 6.94 | Protein levels | Myeloid | 71 | 4 | 11 | 13 | |
| 406 | BAMBI levels | PROLV000177 | 6.93 | Protein levels | Stromal / connective | 10 | 0 | 1 | 10 | |
| 407 | Risk-taking behaviour | BEHAV000013 | 6.91 | Behavioural | Neural / glial | 77 | 5 | 7 | 24 | |
| 408 | CRTAM levels | PROLV000530 | 6.90 | Protein levels | Lymphocyte | 122 | 2 | 13 | 20 | |
| 409 | TNFRSF11A levels | PROLV002060 | 6.87 | Protein levels | B / plasma cell | 31 | 1 | 4 | 8 | |
| 410 | TNF/TNFRSF1B ratio | PRORT001844 | 6.86 | Protein ratios | Myeloid | 28 | 3 | 19 | 28 | |
| 411 | ADGRE1 levels | PROLV000042 | 6.84 | Protein levels | Myeloid | 90 | 4 | 8 | 17 | |
| 412 | DKK3 levels | PROLV000621 | 6.83 | Protein levels | Myeloid | 56 | 3 | 10 | 17 | |
| 413 | CLEC4G/NELL2 ratio | PRORT000662 | 6.78 | Protein ratios | Myeloid | 35 | 5 | 16 | 39 | |
| 414 | Xenobiotic metabolites | METAB000080 | 6.77 | Metabolites | Hepatocyte | 26 | 1 | 3 | 11 | |
| 415 | FABP1/LGALS4 ratio | PRORT001095 | 6.73 | Protein ratios | Hepatocyte | 27 | 1 | 9 | 21 | |
| 416 | Seborrhoeic dermatitis | DERMA000020 | 6.73 | Dermatologic | Lymphocyte | 98 | 2 | 16 | 19 | |
| 417 | NUDT5/TXNRD1 ratio | PRORT001611 | 6.72 | Protein ratios | Granulosa cell | 19 | 5 | 8 | 9 | |
| 418 | Thyroid disorder | ENDOC000023 | 6.72 | Endocrine | Lymphocyte | 189 | 1 | 10 | 25 | |
| 419 | CEACAM8/PGLYRP1 ratio | PRORT000588 | 6.63 | Protein ratios | Myeloid | 52 | 3 | 13 | 20 | |
| 420 | Sexual behaviour | BEHAV000012 | 6.59 | Behavioural | Neural / glial | 200 | 5 | 8 | 22 | |
| 421 | CD163/ICAM1 ratio | PRORT000381 | 6.57 | Protein ratios | Myeloid | 21 | 5 | 19 | 38 | |
| 422 | Eosinophil | HEMAT000030 | 6.57 | Hematologic | Lymphocyte | 1,935 | 2 | 16 | 25 | |
| 423 | Aplastic anaemia | HEMAT000004 | 6.56 | Hematologic | Muscle / cardiac | 0 | 2 | 5 | 18 | |
| 424 | Allergic disease | IMMUN000003 | 6.56 | Immunologic | Lymphocyte | 228 | 2 | 12 | 17 | |
| 425 | DIABLO/PDGFB ratio | PRORT000892 | 6.56 | Protein ratios | Myeloid | 1 | 4 | 10 | 17 | |
| 426 | PLXNB2 levels | PROLV001586 | 6.50 | Protein levels | Hepatocyte | 124 | 2 | 6 | 21 | |
| 427 | CA1/HMBS ratio | PRORT000269 | 6.50 | Protein ratios | Lymphocyte | 14 | 4 | 20 | 40 | |
| 428 | CD244/TREML2 ratio | PRORT000410 | 6.49 | Protein ratios | Myeloid | 33 | 5 | 16 | 23 | |
| 429 | Supplement use, dietary | DTSUP000024 | 6.46 | Diet and Supplement | Neural / glial | 7 | 5 | 10 | 20 | |
| 430 | MGLL/STK4 ratio | PRORT001531 | 6.46 | Protein ratios | Hepatocyte | 36 | 1 | 7 | 15 | |
| 431 | CRTAM/VCAM1 ratio | PRORT000775 | 6.45 | Protein ratios | Lymphocyte | 13 | 2 | 15 | 27 | |
| 432 | PGLYRP1 levels | PROLV001546 | 6.44 | Protein levels | Myeloid | 82 | 4 | 8 | 9 | |
| 433 | PTN levels | PROLV001669 | 6.44 | Protein levels | Hepatocyte | 35 | 5 | 12 | 30 | |
| 434 | MMP1 levels | PROLV001321 | 6.42 | Protein levels | Hematopoietic progenitor | 57 | 6 | 11 | 19 | |
| 435 | Hospital discharge | MISCL000023 | 6.42 | Miscellaneous | Lymphocyte | 2 | 1 | 10 | 39 | |
| 436 | Stressful life events, none | PSYCH000050 | 6.39 | Psychiatric | Neural / glial | 7 | 6 | 15 | 10 | |
| 437 | Skin and soft tissue infection | IMMUN000073 | 6.37 | Immunologic | B / plasma cell | 9 | 1 | 8 | 22 | |
| 438 | Mosaic chromosomal alteration | MISCL000014 | 6.33 | Miscellaneous | Hematopoietic progenitor | 143 | 3 | 12 | 18 | |
| 439 | AK1 levels | PROLV000070 | 6.30 | Protein levels | B / plasma cell | 0 | 3 | 15 | 48 | |
| 440 | Heme malignancy, Lymphoma | MALIG000044 | 6.26 | Malignancy | B / plasma cell | 27 | 2 | 6 | 28 | |
| 441 | LAIR2 levels | PROLV001177 | 6.26 | Protein levels | Lymphocyte | 49 | 2 | 12 | 22 | |
| 442 | GZMB levels | PROLV000948 | 6.22 | Protein levels | Lymphocyte | 108 | 3 | 14 | 28 | |
| 443 | PDGFA/SPARC ratio | PRORT001637 | 6.21 | Protein ratios | Hematopoietic progenitor | 6 | 3 | 6 | 15 | |
| 444 | PPP2R2A levels | PROLV001618 | 6.21 | Protein levels | Lymphocyte | 0 | 3 | 9 | 29 | |
| 445 | Occupational physical activity | BEHAV000006 | 6.19 | Behavioural | Neural / glial | 28 | 4 | 8 | 20 | |
| 446 | RNASET2 levels | PROLV001742 | 6.18 | Protein levels | Myeloid | 94 | 2 | 9 | 15 | |
| 447 | SULT2A1 levels | PROLV001974 | 6.17 | Protein levels | Hepatocyte | 51 | 1 | 4 | 21 | |
| 448 | Irritable bowel syndrome | GASTR000004 | 6.16 | Gastrointestinal | Neural / glial | 3 | 2 | 7 | 23 | |
| 449 | ITGB1BP2/PTPN6 ratio | PRORT001386 | 6.15 | Protein ratios | Hematopoietic progenitor | 21 | 6 | 14 | 34 | |
| 450 | Purine metabolites | METAB000062 | 6.15 | Metabolites | Hepatocyte | 3 | 1 | 5 | 13 | |
| 451 | PPP1R2/TACC3 ratio | PRORT001705 | 6.15 | Protein ratios | Lymphocyte | 3 | 3 | 10 | 25 | |
| 452 | FCAMR levels | PROLV000774 | 6.13 | Protein levels | Hepatocyte | 81 | 2 | 8 | 20 | |
| 453 | FCRL3 levels | PROLV000785 | 6.11 | Protein levels | Lymphocyte | 48 | 2 | 9 | 18 | |
| 454 | ST6GAL1 levels | PROLV001953 | 6.11 | Protein levels | Myeloid | 81 | 3 | 11 | 16 | |
| 455 | TAX1BP3 levels | PROLV001995 | 6.11 | Protein levels | Myeloid | 0 | 2 | 5 | 6 | |
| 456 | Chest pain | CARDI000052 | 6.10 | Cardiac | Neural / glial | 19 | 4 | 16 | 46 | |
| 457 | Handedness | BEHAV000003 | 6.10 | Behavioural | Neural / glial | 0 | 5 | 14 | 31 | |
| 458 | MEPE levels | PROLV001299 | 6.09 | Protein levels | Muscle / cardiac | 39 | 2 | 7 | 17 | |
| 459 | CEACAM8/VNN2 ratio | PRORT000590 | 6.08 | Protein ratios | Myeloid | 39 | 2 | 8 | 13 | |
| 460 | LCN2/PRTN3 ratio | PRORT001442 | 6.04 | Protein ratios | Myeloid | 25 | 3 | 10 | 13 | |
| 461 | Gut microbial pathway abundance | GASTR000038 | 6.04 | Gastrointestinal | Hepatocyte | 0 | 3 | 9 | 26 | |
| 462 | CEBPB levels | PROLV000395 | 6.04 | Protein levels | Hepatocyte | 20 | 2 | 7 | 16 | |
| 463 | Ventricular mass | CARDI000012 | 6.04 | Cardiac | Muscle / cardiac | 10 | 3 | 10 | 25 | |
| 464 | HDAC8 levels | PROLV000958 | 6.03 | Protein levels | B / plasma cell | — | 1 | 12 | 24 | |
| 465 | Vitamin B12 deficiency anaemia | HEMAT000014 | 6.01 | Hematologic | Lymphocyte | 25 | 1 | 6 | 10 | |
| 466 | PBLD levels | PROLV001500 | 6.00 | Protein levels | Muscle / cardiac | 5 | 6 | 18 | 62 | |
| 467 | PDCD6IP levels | PROLV001519 | 6.00 | Protein levels | Muscle / cardiac | 0 | 4 | 11 | 18 | |
| 468 | XRCC4 levels | PROLV002200 | 6.00 | Protein levels | Myeloid | 0 | 4 | 9 | 17 | |
| 469 | TSC1 levels | PROLV002112 | 5.98 | Protein levels | Hepatocyte | 18 | 5 | 23 | 29 | |
| 470 | IL2RB levels | PROLV001070 | 5.96 | Protein levels | Lymphocyte | 0 | 2 | 8 | 33 | |
| 471 | PITHD1 levels | PROLV001563 | 5.95 | Protein levels | Vascular | 0 | 1 | 6 | 10 | |
| 472 | LAYN/VWC2 ratio | PRORT001436 | 5.93 | Protein ratios | Hepatocyte | 3 | 3 | 10 | 17 | |
| 473 | PLXNA4/SRPK2 ratio | PRORT001686 | 5.88 | Protein ratios | Muscle / cardiac | 7 | 3 | 10 | 37 | |
| 474 | Polyarthropathy | MSKEL000019 | 5.87 | Musculoskeletal | Lymphocyte | 65 | 2 | 13 | 23 | |
| 475 | Exercise workload | CARDI000024 | 5.86 | Cardiac | Neural / glial | 0 | 5 | 11 | 28 | |
| 476 | CTSZ/HSPG2 ratio | PRORT000804 | 5.86 | Protein ratios | Hepatocyte | 35 | 5 | 12 | 20 | |
| 477 | Memory function | PSYCH000007 | 5.86 | Psychiatric | Neural / glial | 45 | 1 | 6 | 10 | |
| 478 | Heart failure, congestive | CARDI000004 | 5.86 | Cardiac | Muscle / cardiac | 6 | 2 | 5 | 14 | |
| 479 | CCN2/VEGFC ratio | PRORT000371 | 5.85 | Protein ratios | Hematopoietic progenitor | 24 | 4 | 9 | 19 | |
| 480 | F9/FURIN ratio | PRORT001091 | 5.84 | Protein ratios | Myeloid | 3 | 2 | 10 | 13 | |
| 481 | DNMBP/WWP2 ratio | PRORT000934 | 5.83 | Protein ratios | Lymphocyte | 12 | 2 | 12 | 42 | |
| 482 | Hypertriglyceridaemia | METBL000023 | 5.83 | Metabolic | Hepatocyte | 117 | 1 | 5 | 20 | |
| 483 | DMP1 levels | PROLV000628 | 5.82 | Protein levels | Myeloid | 89 | 3 | 8 | 11 | |
| 484 | Telomere length | AGING000001 | 5.82 | Aging | Hematopoietic progenitor | 228 | 2 | 10 | 22 | |
| 485 | Exotropia | OPHTH000022 | 5.80 | Ophthalmic | Myeloid | 6 | 1 | 8 | 7 | |
| 486 | CD6/EZR ratio | PRORT000484 | 5.80 | Protein ratios | Myeloid | 15 | 5 | 18 | 43 | |
| 487 | IGSF21 levels | PROLV001037 | 5.80 | Protein levels | Myeloid | 49 | 3 | 9 | 13 | |
| 488 | DBNL/VASH1 ratio | PRORT000869 | 5.79 | Protein ratios | Muscle / cardiac | 0 | 2 | 9 | 14 | |
| 489 | FXYD5/TMSB10 ratio | PRORT001196 | 5.79 | Protein ratios | Muscle / cardiac | 6 | 3 | 6 | 18 | |
| 490 | Skin eruption | DERMA000027 | 5.78 | Dermatologic | Lymphocyte | 0 | 2 | 14 | 20 | |
| 491 | S100A14 levels | PROLV001769 | 5.78 | Protein levels | Hepatocyte | 25 | 3 | 11 | 21 | |
| 492 | CD70 levels | PROLV000353 | 5.77 | Protein levels | Muscle / cardiac | 6 | 3 | 11 | 20 | |
| 493 | ROR1/TNFRSF21 ratio | PRORT001748 | 5.76 | Protein ratios | Lymphocyte | 8 | 5 | 11 | 19 | |
| 494 | CD163 levels | PROLV000312 | 5.76 | Protein levels | Myeloid | 134 | 4 | 13 | 17 | |
| 495 | UXS1 levels | PROLV002147 | 5.76 | Protein levels | Myeloid | 16 | 2 | 8 | 9 | |
| 496 | CXCL11 levels | PROLV000577 | 5.75 | Protein levels | Myeloid | 47 | 4 | 9 | 18 | |
| 497 | PDCD1 levels | PROLV001515 | 5.75 | Protein levels | Lymphocyte | 69 | 2 | 13 | 19 | |
| 498 | CLEC14A/EPHB4 ratio | PRORT000626 | 5.75 | Protein ratios | Vascular | 10 | 3 | 7 | 17 | |
| 499 | PDZK1 levels | PROLV001531 | 5.74 | Protein levels | Hepatocyte | 27 | 3 | 12 | 25 | |
| 500 | FOXO1/USP8 ratio | PRORT001177 | 5.72 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 33 | |
| 501 | Neoplasm, Skin | MALIG000034 | 5.71 | Malignancy | Myeloid | 88 | 4 | 12 | 22 | |
| 502 | Cardiac pacemaker | CARDI000049 | 5.70 | Cardiac | Muscle / cardiac | 22 | 3 | 14 | 22 | |
| 503 | ICAM2/IL7R ratio | PRORT001324 | 5.69 | Protein ratios | Vascular | 6 | 1 | 8 | 17 | |
| 504 | Social relationships | SOCIO000021 | 5.69 | Socioeconomic | Neural / glial | 17 | 5 | 9 | 17 | |
| 505 | Connective tissue disorder | MSKEL000060 | 5.69 | Musculoskeletal | Myeloid | 44 | 1 | 4 | 21 | |
| 506 | COL28A1 levels | PROLV000487 | 5.69 | Protein levels | B / plasma cell | 11 | 0 | 4 | 14 | |
| 507 | SLC4A1 levels | PROLV001882 | 5.67 | Protein levels | Lymphocyte | 0 | 3 | 7 | 28 | |
| 508 | ADM/CLMP ratio | PRORT000045 | 5.65 | Protein ratios | B / plasma cell | 16 | 2 | 6 | 8 | |
| 509 | CD79B/FCRL2 ratio | PRORT000511 | 5.63 | Protein ratios | Stromal / connective | 17 | 2 | 7 | 12 | |
| 510 | RARRES2/ST6GAL1 ratio | PRORT001727 | 5.63 | Protein ratios | Myeloid | 42 | 1 | 6 | 8 | |
| 511 | STX6 levels | PROLV001969 | 5.61 | Protein levels | Lymphocyte | 0 | 3 | 10 | 16 | |
| 512 | IL12RB1 levels | PROLV001046 | 5.60 | Protein levels | Muscle / cardiac | 54 | 5 | 14 | 18 | |
| 513 | CD27/NECTIN4 ratio | PRORT000416 | 5.60 | Protein ratios | Lymphocyte | 15 | 2 | 13 | 34 | |
| 514 | IL10 levels | PROLV001042 | 5.58 | Protein levels | Lymphocyte | 50 | 1 | 13 | 25 | |
| 515 | Loneliness | PSYCH000055 | 5.54 | Psychiatric | Neural / glial | 1 | 2 | 10 | 17 | |
| 516 | ITGB7 levels | PROLV001116 | 5.52 | Protein levels | Hepatocyte | 157 | 4 | 17 | 37 | |
| 517 | Tendinitis | MSKEL000070 | 5.50 | Musculoskeletal | Neural / glial | 0 | 1 | 3 | 9 | |
| 518 | IGDCC4 levels | PROLV001024 | 5.48 | Protein levels | Myeloid | 46 | 4 | 11 | 16 | |
| 519 | S100A11/SERPINB8 ratio | PRORT001754 | 5.48 | Protein ratios | Myeloid | 17 | 3 | 8 | 13 | |
| 520 | TIE1 levels | PROLV002033 | 5.46 | Protein levels | Granulosa cell | 77 | 3 | 9 | 20 | |
| 521 | CD6 levels | PROLV000349 | 5.45 | Protein levels | Lymphocyte | 89 | 2 | 19 | 32 | |
| 522 | Digestive system disorder | GASTR000006 | 5.45 | Gastrointestinal | Vascular | 60 | 0 | 7 | 16 | |
| 523 | STC1 levels | PROLV001960 | 5.44 | Protein levels | Vascular | 2 | 1 | 6 | 12 | |
| 524 | CALCOCO1/TJAP1 ratio | PRORT000303 | 5.44 | Protein ratios | Muscle / cardiac | 0 | 4 | 14 | 32 | |
| 525 | CLEC11A levels | PROLV000445 | 5.43 | Protein levels | Hematopoietic progenitor | 65 | 3 | 5 | 10 | |
| 526 | GPC1 levels | PROLV000919 | 5.43 | Protein levels | Muscle / cardiac | 104 | 2 | 6 | 8 | |
| 527 | Sun exposure | BEHAV000001 | 5.43 | Behavioural | Neural / glial | 80 | 3 | 7 | 21 | |
| 528 | LCN2/RETN ratio | PRORT001443 | 5.42 | Protein ratios | Myeloid | 41 | 2 | 8 | 14 | |
| 529 | AZU1/CEACAM8 ratio | PRORT000184 | 5.41 | Protein ratios | Myeloid | 24 | 2 | 5 | 14 | |
| 530 | GBP6 levels | PROLV000863 | 5.41 | Protein levels | Hepatocyte | 11 | 2 | 9 | 14 | |
| 531 | External ear disorder | AUDIO000001 | 5.39 | Auditory | Hepatocyte | 0 | 2 | 8 | 19 | |
| 532 | Memory disorder | PSYCH000006 | 5.39 | Psychiatric | Neural / glial | 1 | 1 | 4 | 8 | |
| 533 | Ovarian dysfunction | REPRO000023 | 5.39 | Reproductive | Granulosa cell | 1 | 4 | 9 | 21 | |
| 534 | CRTAM/TNFRSF9 ratio | PRORT000774 | 5.39 | Protein ratios | Lymphocyte | 7 | 3 | 17 | 30 | |
| 535 | Upper respiratory tract disease | RESPI000042 | 5.38 | Respiratory | Lymphocyte | 13 | 2 | 19 | 32 | |
| 536 | TACC3/TBC1D23 ratio | PRORT001824 | 5.37 | Protein ratios | Lymphocyte | 2 | 2 | 9 | 18 | |
| 537 | CD163/MARCO ratio | PRORT000383 | 5.36 | Protein ratios | Myeloid | 64 | 4 | 11 | 20 | |
| 538 | L1CAM levels | PROLV001171 | 5.36 | Protein levels | Vascular | 70 | 6 | 12 | 37 | |
| 539 | Grain and bakery preference | DTSUP000013 | 5.34 | Diet and Supplement | Neural / glial | 49 | 4 | 9 | 22 | |
| 540 | Psoriatic arthritis | IMMUN000040 | 5.33 | Immunologic | Lymphocyte | 88 | 2 | 15 | 20 | |
| 541 | Sedentary behaviour | BEHAV000008 | 5.31 | Behavioural | Neural / glial | 111 | 4 | 9 | 20 | |
| 542 | Pregnancy termination | BEHAV000010 | 5.30 | Behavioural | Neural / glial | 0 | 6 | 9 | 19 | |
| 543 | CEP85/ZBTB16 ratio | PRORT000604 | 5.30 | Protein ratios | Muscle / cardiac | 20 | 3 | 12 | 18 | |
| 544 | Joint disorder | MSKEL000015 | 5.30 | Musculoskeletal | Stromal / connective | 2 | 3 | 10 | 14 | |
| 545 | MNDA levels | PROLV001329 | 5.29 | Protein levels | Muscle / cardiac | 1 | 4 | 10 | 20 | |
| 546 | CRTAM/PDCD1 ratio | PRORT000773 | 5.28 | Protein ratios | Lymphocyte | 7 | 2 | 19 | 43 | |
| 547 | FKBP4 levels | PROLV000809 | 5.28 | Protein levels | Lymphocyte | 2 | 5 | 15 | 40 | |
| 548 | Membranous nephropathy | NEPHR000008 | 5.26 | Nephrourologic | Myeloid | 15 | 7 | 16 | 25 | |
| 549 | Alcohol consumption | PSYCH000041 | 5.26 | Psychiatric | Neural / glial | 63 | 4 | 9 | 18 | |
| 550 | AGR2 levels | PROLV000055 | 5.25 | Protein levels | Pancreatic epithelium | 26 | 0 | 8 | 13 | |
| 551 | KYNU/SCLY ratio | PRORT001416 | 5.24 | Protein ratios | Hepatocyte | 7 | 4 | 16 | 39 | |
| 552 | Psoriatic arthritis vs psoriasis | IMMUN000041 | 5.23 | Immunologic | Neural / glial | 7 | 3 | 10 | 12 | |
| 553 | CD93/CLEC14A ratio | PRORT000531 | 5.23 | Protein ratios | Neural / glial | 3 | 2 | 8 | 17 | |
| 554 | PM20D1 levels | PROLV001588 | 5.21 | Protein levels | Granulosa cell | 34 | 2 | 10 | 19 | |
| 555 | Pregnancy complication, oedema | REPRO000032 | 5.20 | Reproductive | B / plasma cell | 3 | 0 | 3 | 2 | |
| 556 | CTHRC1 levels | PROLV000556 | 5.18 | Protein levels | Myeloid | 27 | 4 | 11 | 12 | |
| 557 | PRL levels | PROLV001635 | 5.18 | Protein levels | Lymphocyte | 17 | 2 | 9 | 27 | |
| 558 | HAVCR2 levels | PROLV000954 | 5.14 | Protein levels | Myeloid | 31 | 0 | 3 | 11 | |
| 559 | C1QA levels | PROLV000222 | 5.14 | Protein levels | Myeloid | 186 | 2 | 8 | 10 | |
| 560 | EIF4G1/NFATC1 ratio | PRORT001012 | 5.14 | Protein ratios | Myeloid | 0 | 1 | 8 | 14 | |
| 561 | Cardiac conduction disorder | CARDI000030 | 5.14 | Cardiac | Muscle / cardiac | 14 | 3 | 6 | 13 | |
| 562 | Sugar alcohols | METAB000037 | 5.14 | Metabolites | Vascular | 0 | 1 | 4 | 12 | |
| 563 | BLMH/PEAR1 ratio | PRORT000236 | 5.13 | Protein ratios | Hepatocyte | 17 | 3 | 13 | 15 | |
| 564 | Dyspnoea | RESPI000028 | 5.12 | Respiratory | Neural / glial | 21 | 5 | 12 | 41 | |
| 565 | NFASC levels | PROLV001394 | 5.12 | Protein levels | Hepatocyte | 57 | 3 | 12 | 27 | |
| 566 | PRAP1 levels | PROLV001623 | 5.11 | Protein levels | Hematopoietic progenitor | 16 | 2 | 6 | 11 | |
| 567 | PIK3IP1/RGMB ratio | PRORT001665 | 5.11 | Protein ratios | Neural / glial | 0 | 0 | 8 | 11 | |
| 568 | Operation, respiratory | RESPI000025 | 5.10 | Respiratory | Vascular | 61 | 3 | 12 | 22 | |
| 569 | Implantable cardioverter-defibrillator | CARDI000050 | 5.10 | Cardiac | Muscle / cardiac | 18 | 2 | 5 | 10 | |
| 570 | Flavour preference | DTSUP000022 | 5.09 | Diet and Supplement | Neural / glial | 94 | 3 | 8 | 18 | |
| 571 | DXO levels | PROLV000665 | 5.09 | Protein levels | Lymphocyte | 32 | 5 | 11 | 35 | |
| 572 | Conjunctivitis | OPHTH000002 | 5.09 | Ophthalmic | Lymphocyte | 26 | 3 | 10 | 30 | |
| 573 | Pain, neck | MSKEL000040 | 5.09 | Musculoskeletal | Neural / glial | 3 | 3 | 16 | 34 | |
| 574 | Skin keratoses, seborrhoeic | DERMA000022 | 5.09 | Dermatologic | Hepatocyte | 13 | 1 | 12 | 26 | |
| 575 | Immune cell marker, B cell | HEMAT000021 | 5.07 | Hematologic | Myeloid | 24 | 0 | 3 | 10 | |
| 576 | FAM3B/GPA33 ratio | PRORT001113 | 5.06 | Protein ratios | Vascular | 17 | 0 | 4 | 7 | |
| 577 | ELOA/MAD1L1 ratio | PRORT001015 | 5.04 | Protein ratios | Myeloid | 4 | 3 | 9 | 15 | |
| 578 | Social activity | SOCIO000020 | 5.01 | Socioeconomic | Neural / glial | 22 | 4 | 10 | 18 | |
| 579 | Retinal vascular disorder | OPHTH000044 | 5.01 | Ophthalmic | Vascular | 0 | 1 | 6 | 13 | |
| 580 | BANK1/FOXO1 ratio | PRORT000204 | 5.01 | Protein ratios | Muscle / cardiac | 2 | 3 | 9 | 19 | |
| 581 | Medication, anti-asthmatic | IMMUN000082 | 5.01 | Immunologic | Lymphocyte | 36 | 1 | 8 | 22 | |
| 582 | Household income | SOCIO000026 | 5.01 | Socioeconomic | Neural / glial | 40 | 5 | 12 | 47 | |
| 583 | SNAP25 levels | PROLV001906 | 4.98 | Protein levels | Muscle / cardiac | 18 | 1 | 5 | 11 | |
| 584 | Mood symptoms | PSYCH000029 | 4.98 | Psychiatric | Neural / glial | 41 | 3 | 7 | 10 | |
| 585 | NBN levels | PROLV001376 | 4.96 | Protein levels | Lymphocyte | 10 | 2 | 14 | 38 | |
| 586 | Pain, none | MSKEL000041 | 4.96 | Musculoskeletal | Neural / glial | 10 | 7 | 9 | 20 | |
| 587 | LAT2/SDC4 ratio | PRORT001430 | 4.95 | Protein ratios | Myeloid | 3 | 5 | 10 | 24 | |
| 588 | Social and economic stability | SOCIO000028 | 4.95 | Socioeconomic | Neural / glial | 0 | 4 | 7 | 26 | |
| 589 | DAPP1/ITGB1BP2 ratio | PRORT000854 | 4.95 | Protein ratios | Myeloid | 21 | 5 | 19 | 31 | |
| 590 | IL22 levels | PROLV001066 | 4.94 | Protein levels | Melanocyte | 14 | 1 | 6 | 12 | |
| 591 | CD244 levels | PROLV000322 | 4.94 | Protein levels | Muscle / cardiac | 28 | 4 | 19 | 38 | |
| 592 | DCTPP1 levels | PROLV000605 | 4.94 | Protein levels | Myeloid | 47 | 2 | 11 | 16 | |
| 593 | LGALS4/PCDH17 ratio | PRORT001450 | 4.94 | Protein ratios | B / plasma cell | 4 | 2 | 6 | 10 | |
| 594 | Pregnancy complication, abortive | REPRO000027 | 4.93 | Reproductive | Neural / glial | 0 | 5 | 7 | 18 | |
| 595 | Body fat percentage, sex interaction | BCOMP000002 | 4.93 | Body composition | Muscle / cardiac | 0 | 2 | 6 | 13 | |
| 596 | F2R/TNFRSF14 ratio | PRORT001085 | 4.93 | Protein ratios | Lymphocyte | 15 | 3 | 9 | 34 | |
| 597 | PPP1R14D levels | PROLV001615 | 4.89 | Protein levels | Lymphocyte | 15 | 2 | 14 | 33 | |
| 598 | Peripheral nerve disorder | NEURO000031 | 4.89 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 599 | Pneumonia | IMMUN000069 | 4.88 | Immunologic | Hepatocyte | 27 | 1 | 4 | 13 | |
| 600 | RILP levels | PROLV001734 | 4.87 | Protein levels | Lymphocyte | 22 | 2 | 15 | 42 | |
| 601 | Age at onset of walking | NEURO000023 | 4.87 | Neurologic | Neural / glial | 11 | 5 | 12 | 21 | |
| 602 | CRADD/HSPA1A ratio | PRORT000747 | 4.87 | Protein ratios | Neural / glial | 20 | 3 | 6 | 17 | |
| 603 | BLVRB/CA1 ratio | PRORT000238 | 4.85 | Protein ratios | Myeloid | 1 | 2 | 5 | 11 | |
| 604 | Excessive sweating | DERMA000029 | 4.85 | Dermatologic | Myeloid | 4 | 1 | 3 | 3 | |
| 605 | ARNT levels | PROLV000144 | 4.83 | Protein levels | Myeloid | 24 | 3 | 9 | 11 | |
| 606 | COLEC12/TAFA5 ratio | PRORT000706 | 4.81 | Protein ratios | B / plasma cell | 13 | 1 | 6 | 11 | |
| 607 | DAB2/GRAP2 ratio | PRORT000838 | 4.80 | Protein ratios | Myeloid | 11 | 4 | 9 | 17 | |
| 608 | CLEC4G/MERTK ratio | PRORT000661 | 4.79 | Protein ratios | Myeloid | 78 | 5 | 18 | 29 | |
| 609 | HPCAL1/PMVK ratio | PRORT001298 | 4.77 | Protein ratios | Myeloid | 1 | 3 | 11 | 25 | |
| 610 | Medication, Crohn disease | IMMUN000081 | 4.75 | Immunologic | Lymphocyte | 132 | 2 | 17 | 10 | |
| 611 | SUOX levels | PROLV001977 | 4.75 | Protein levels | Hepatocyte | 27 | 1 | 13 | 31 | |
| 612 | Eustachian tube disorder | AUDIO000015 | 4.74 | Auditory | Epithelial | 0 | 0 | 6 | 8 | |
| 613 | NAP1L4 levels | PROLV001374 | 4.74 | Protein levels | Lymphocyte | 15 | 3 | 9 | 33 | |
| 614 | YOD1 levels | PROLV002206 | 4.73 | Protein levels | Lymphocyte | 0 | 4 | 12 | 40 | |
| 615 | LCN2/S100A12 ratio | PRORT001444 | 4.72 | Protein ratios | Myeloid | 28 | 4 | 18 | 35 | |
| 616 | CRTAM/GZMA ratio | PRORT000769 | 4.71 | Protein ratios | Lymphocyte | 34 | 3 | 14 | 33 | |
| 617 | CD58/MEGF10 ratio | PRORT000477 | 4.70 | Protein ratios | Muscle / cardiac | 15 | 5 | 19 | 37 | |
| 618 | Biliverdin | HPBIL000018 | 4.69 | Hepatopancreatobiliary | Lymphocyte | 0 | 0 | 10 | 17 | |
| 619 | FCRL5/MZB1 ratio | PRORT001135 | 4.69 | Protein ratios | B / plasma cell | 4 | 2 | 3 | 3 | |
| 620 | CXCL6/DFFA ratio | PRORT000834 | 4.69 | Protein ratios | Hepatocyte | 2 | 2 | 9 | 18 | |
| 621 | ICAM3 levels | PROLV001006 | 4.69 | Protein levels | B / plasma cell | 143 | 2 | 12 | 18 | |
| 622 | NPHS1 levels | PROLV001421 | 4.68 | Protein levels | Lymphocyte | 9 | 2 | 6 | 8 | |
| 623 | CCNE1 levels | PROLV000306 | 4.68 | Protein levels | B / plasma cell | 8 | 0 | 6 | 17 | |
| 624 | MMP8/OLR1 ratio | PRORT001543 | 4.68 | Protein ratios | Myeloid | 9 | 3 | 10 | 21 | |
| 625 | CST3/CTSZ ratio | PRORT000780 | 4.68 | Protein ratios | Hepatocyte | 4 | 3 | 8 | 14 | |
| 626 | LAIR1 levels | PROLV001176 | 4.67 | Protein levels | Myeloid | 23 | 4 | 9 | 17 | |
| 627 | GLB1 levels | PROLV000894 | 4.66 | Protein levels | Hepatocyte | 103 | 4 | 10 | 19 | |
| 628 | IGFBP2 levels | PROLV001029 | 4.66 | Protein levels | Muscle / cardiac | 58 | 2 | 4 | 14 | |
| 629 | ITGAL levels | PROLV001108 | 4.66 | Protein levels | Lymphocyte | 15 | 2 | 17 | 37 | |
| 630 | FOLR3/KLK8 ratio | PRORT001171 | 4.66 | Protein ratios | Myeloid | 24 | 2 | 10 | 15 | |
| 631 | Circadian timing | BEHAV000014 | 4.66 | Behavioural | Neural / glial | 79 | 2 | 9 | 16 | |
| 632 | CD55/ITGB1 ratio | PRORT000470 | 4.65 | Protein ratios | Vascular | 51 | 2 | 8 | 22 | |
| 633 | PRR4 levels | PROLV001642 | 4.65 | Protein levels | Epithelial | 44 | 0 | 8 | 9 | |
| 634 | THOP1 levels | PROLV002028 | 4.65 | Protein levels | Muscle / cardiac | 14 | 5 | 6 | 13 | |
| 635 | CRISP2 levels | PROLV000524 | 4.64 | Protein levels | Lymphocyte | 3 | 1 | 9 | 12 | |
| 636 | Ceramides | LIPID000065 | 4.64 | Lipids | Hepatocyte | 6 | 1 | 3 | 15 | |
| 637 | GNS levels | PROLV000907 | 4.64 | Protein levels | Myeloid | 0 | 1 | 7 | 13 | |
| 638 | Respiratory symptom | RESPI000032 | 4.63 | Respiratory | Neural / glial | 10 | 4 | 12 | 19 | |
| 639 | CASP3/LYN ratio | PRORT000314 | 4.63 | Protein ratios | Myeloid | 1 | 2 | 14 | 44 | |
| 640 | Bleeding | HEMAT000016 | 4.63 | Hematologic | B / plasma cell | 9 | 1 | 4 | 17 | |
| 641 | SNAP29/VEGFC ratio | PRORT001800 | 4.62 | Protein ratios | Lymphocyte | 5 | 2 | 8 | 38 | |
| 642 | ITGB2 levels | PROLV001113 | 4.60 | Protein levels | Myeloid | 155 | 2 | 18 | 27 | |
| 643 | ATF6 levels | PROLV000157 | 4.59 | Protein levels | Myeloid | 5 | 4 | 11 | 19 | |
| 644 | CXCL10 levels | PROLV000576 | 4.59 | Protein levels | Myeloid | 89 | 2 | 9 | 19 | |
| 645 | CFC1 levels | PROLV000411 | 4.59 | Protein levels | Hematopoietic progenitor | 4 | 1 | 3 | 5 | |
| 646 | TNFSF13 levels | PROLV002078 | 4.58 | Protein levels | Myeloid | 71 | 3 | 8 | 12 | |
| 647 | MZB1 levels | PROLV001366 | 4.57 | Protein levels | Lymphocyte | 62 | 2 | 12 | 17 | |
| 648 | CD28 levels | PROLV000327 | 4.57 | Protein levels | B / plasma cell | 26 | 1 | 10 | 17 | |
| 649 | GZMA/TNFRSF8 ratio | PRORT001262 | 4.56 | Protein ratios | Lymphocyte | 48 | 4 | 14 | 44 | |
| 650 | ERP29 levels | PROLV000731 | 4.55 | Protein levels | Hematopoietic progenitor | 17 | 1 | 2 | 4 | |
| 651 | Dermatitis and eczema | DERMA000008 | 4.55 | Dermatologic | Lymphocyte | 129 | 1 | 12 | 18 | |
| 652 | Narcolepsy | NEURO000036 | 4.54 | Neurologic | Neural / glial | 17 | 4 | 13 | 30 | |
| 653 | Employment status | SOCIO000005 | 4.54 | Socioeconomic | Neural / glial | 0 | 3 | 5 | 21 | |
| 654 | MMP9/OSM ratio | PRORT001547 | 4.51 | Protein ratios | Myeloid | 6 | 2 | 8 | 9 | |
| 655 | ICAM3/SLAMF7 ratio | PRORT001328 | 4.50 | Protein ratios | Myeloid | 27 | 3 | 19 | 22 | |
| 656 | MAP3K5/ZBTB16 ratio | PRORT001489 | 4.49 | Protein ratios | Muscle / cardiac | 10 | 5 | 9 | 25 | |
| 657 | CDKN1A/TXLNA ratio | PRORT000575 | 4.48 | Protein ratios | Myeloid | 15 | 4 | 12 | 14 | |
| 658 | CD74/JAM2 ratio | PRORT000504 | 4.47 | Protein ratios | Myeloid | 51 | 4 | 10 | 17 | |
| 659 | NPTXR levels | PROLV001428 | 4.47 | Protein levels | Myeloid | 28 | 1 | 6 | 14 | |
| 660 | Transport mode | BEHAV000009 | 4.44 | Behavioural | Neural / glial | 17 | 4 | 7 | 10 | |
| 661 | TNFSF14 levels | PROLV002080 | 4.43 | Protein levels | Myeloid | 15 | 2 | 6 | 24 | |
| 662 | Knee derangements | MSKEL000016 | 4.43 | Musculoskeletal | Stromal / connective | 5 | 1 | 2 | 7 | |
| 663 | Personality disorder | PSYCH000035 | 4.42 | Psychiatric | Hepatocyte | 0 | 1 | 5 | 15 | |
| 664 | TNFRSF8 levels | PROLV002073 | 4.41 | Protein levels | Lymphocyte | 95 | 2 | 20 | 28 | |
| 665 | PTPRR levels | PROLV001680 | 4.41 | Protein levels | Epithelial | 0 | 0 | 7 | 15 | |
| 666 | PSRC1 levels | PROLV001662 | 4.40 | Protein levels | Myeloid | 26 | 3 | 10 | 17 | |
| 667 | Otitis media | AUDIO000017 | 4.40 | Auditory | Myeloid | 33 | 0 | 2 | 4 | |
| 668 | Polyamine metabolites | METAB000059 | 4.39 | Metabolites | Hepatocyte | 1 | 1 | 9 | 17 | |
| 669 | IL12B levels | PROLV001045 | 4.39 | Protein levels | Myeloid | 205 | 3 | 7 | 10 | |
| 670 | TIMD4 levels | PROLV002035 | 4.38 | Protein levels | Myeloid | 181 | 2 | 9 | 21 | |
| 671 | LBR/MAD1L1 ratio | PRORT001438 | 4.37 | Protein ratios | Myeloid | 0 | 3 | 10 | 24 | |
| 672 | FCRL6/GZMA ratio | PRORT001137 | 4.37 | Protein ratios | Lymphocyte | 14 | 2 | 13 | 40 | |
| 673 | KEL levels | PROLV001134 | 4.35 | Protein levels | Hepatocyte | 60 | 3 | 15 | 28 | |
| 674 | TMEM25 levels | PROLV002047 | 4.34 | Protein levels | Hepatocyte | 24 | 1 | 5 | 19 | |
| 675 | ATP5IF1/HSPA1A ratio | PRORT000158 | 4.32 | Protein ratios | Myeloid | 21 | 3 | 7 | 15 | |
| 676 | Heart rate response to exercise | CARDI000025 | 4.32 | Cardiac | Vascular | 12 | 0 | 6 | 5 | |
| 677 | MPHOSPH8/USP8 ratio | PRORT001555 | 4.31 | Protein ratios | Lymphocyte | 0 | 3 | 17 | 44 | |
| 678 | ARSA/CD164 ratio | PRORT000142 | 4.31 | Protein ratios | Hepatocyte | 37 | 3 | 8 | 25 | |
| 679 | Social activity, none | SOCIO000018 | 4.30 | Socioeconomic | Neural / glial | 3 | 4 | 14 | 27 | |
| 680 | Cancer, Thyroid | MALIG000032 | 4.30 | Malignancy | Lymphocyte | 2 | 1 | 9 | 30 | |
| 681 | CWC15 levels | PROLV000572 | 4.30 | Protein levels | Lymphocyte | 7 | 2 | 12 | 34 | |
| 682 | CRKL/MANF ratio | PRORT000764 | 4.28 | Protein ratios | Myeloid | 5 | 4 | 13 | 18 | |
| 683 | PAFAH1B3 levels | PROLV001486 | 4.28 | Protein levels | Lymphocyte | 45 | 2 | 17 | 18 | |
| 684 | SDK2 levels | PROLV001800 | 4.27 | Protein levels | Myeloid | 29 | 3 | 14 | 24 | |
| 685 | CD300A levels | PROLV000329 | 4.27 | Protein levels | Lymphocyte | 39 | 4 | 18 | 41 | |
| 686 | MDH1 levels | PROLV001289 | 4.26 | Protein levels | Myeloid | 2 | 3 | 9 | 19 | |
| 687 | Non-cancer illness burden | MISCL000029 | 4.26 | Miscellaneous | Neural / glial | 24 | 5 | 8 | 15 | |
| 688 | FOXO3 levels | PROLV000826 | 4.25 | Protein levels | Lymphocyte | 3 | 2 | 14 | 20 | |
| 689 | CASP3/SERPINE1 ratio | PRORT000319 | 4.25 | Protein ratios | Muscle / cardiac | 0 | 3 | 14 | 20 | |
| 690 | Carotid intima-media thickness | VASCU000053 | 4.25 | Vascular | Adipose | 15 | 2 | 5 | 12 | |
| 691 | CHMP1A/EREG ratio | PRORT000612 | 4.25 | Protein ratios | Myeloid | 33 | 3 | 14 | 21 | |
| 692 | Nutritional and metabolic symptoms | METBL000016 | 4.24 | Metabolic | Lymphocyte | 0 | 4 | 7 | 28 | |
| 693 | RFC4 levels | PROLV001726 | 4.24 | Protein levels | Stromal / connective | 1 | 4 | 14 | 19 | |
| 694 | LTA/LTBR ratio | PRORT001463 | 4.24 | Protein ratios | B / plasma cell | 14 | 1 | 7 | 32 | |
| 695 | PSRC1/SORT1 ratio | PRORT001715 | 4.24 | Protein ratios | Myeloid | 2 | 3 | 10 | 11 | |
| 696 | IBD-Ulcerative colitis | IMMUN000031 | 4.23 | Immunologic | Myeloid | 239 | 2 | 12 | 28 | |
| 697 | PRR15 levels | PROLV001641 | 4.22 | Protein levels | Epithelial | 0 | 2 | 6 | 9 | |
| 698 | FGF21 levels | PROLV000795 | 4.22 | Protein levels | Hepatocyte | 41 | 2 | 4 | 5 | |
| 699 | DDAH1 levels | PROLV000607 | 4.22 | Protein levels | Myeloid | 3 | 7 | 10 | 19 | |
| 700 | APBB1IP/POLR2F ratio | PRORT000115 | 4.21 | Protein ratios | Myeloid | 11 | 3 | 20 | 34 | |
| 701 | GOPC/IRAK4 ratio | PRORT001224 | 4.20 | Protein ratios | Lymphocyte | 0 | 3 | 11 | 32 | |
| 702 | CC2D1A/CRADD ratio | PRORT000327 | 4.19 | Protein ratios | Myeloid | 1 | 3 | 7 | 21 | |
| 703 | CXCL17/LAMP3 ratio | PRORT000823 | 4.18 | Protein ratios | Myeloid | 6 | 3 | 15 | 38 | |
| 704 | PFKFB2/SRP14 ratio | PRORT001663 | 4.18 | Protein ratios | Hepatocyte | 10 | 5 | 10 | 28 | |
| 705 | Allergic rhinitis | IMMUN000004 | 4.18 | Immunologic | Lymphocyte | 125 | 2 | 14 | 18 | |
| 706 | NOTCH1 levels | PROLV001416 | 4.18 | Protein levels | Hepatocyte | 100 | 2 | 7 | 17 | |
| 707 | CD209/CLEC4G ratio | PRORT000396 | 4.18 | Protein ratios | Neural / glial | 22 | 1 | 7 | 10 | |
| 708 | Triglycerides | LIPID000039 | 4.16 | Lipids | Hepatocyte | 33 | 1 | 3 | 13 | |
| 709 | ITGB1/ITGB2 ratio | PRORT001376 | 4.16 | Protein ratios | Myeloid | 75 | 3 | 15 | 21 | |
| 710 | APBB1IP levels | PROLV000112 | 4.15 | Protein levels | Myeloid | 38 | 4 | 17 | 27 | |
| 711 | FLT3 levels | PROLV000816 | 4.15 | Protein levels | Myeloid | 50 | 4 | 11 | 22 | |
| 712 | PDCD1/TNFRSF4 ratio | PRORT001629 | 4.15 | Protein ratios | Lymphocyte | 11 | 1 | 16 | 18 | |
| 713 | ALCAM/LRRC25 ratio | PRORT000073 | 4.14 | Protein ratios | Myeloid | 48 | 3 | 9 | 17 | |
| 714 | CXCL5/MESD ratio | PRORT000828 | 4.14 | Protein ratios | Lymphocyte | 2 | 3 | 11 | 25 | |
| 715 | ADA levels | PROLV000023 | 4.13 | Protein levels | Myeloid | 17 | 5 | 18 | 32 | |
| 716 | SCARA3 levels | PROLV001779 | 4.12 | Protein levels | Epithelial | 0 | 1 | 16 | 30 | |
| 717 | MAN2B2 levels | PROLV001261 | 4.11 | Protein levels | Hepatocyte | 53 | 4 | 17 | 35 | |
| 718 | GZMH/KLRD1 ratio | PRORT001264 | 4.11 | Protein ratios | Lymphocyte | 35 | 3 | 13 | 36 | |
| 719 | GZMA/TNFRSF4 ratio | PRORT001261 | 4.11 | Protein ratios | Lymphocyte | 36 | 3 | 15 | 35 | |
| 720 | RGMB/SMOC2 ratio | PRORT001737 | 4.10 | Protein ratios | Myeloid | 30 | 4 | 10 | 19 | |
| 721 | Frailty, general | MISCL000039 | 4.09 | Miscellaneous | Neural / glial | 20 | 4 | 7 | 19 | |
| 722 | TGFA levels | PROLV002019 | 4.09 | Protein levels | Myeloid | 15 | 2 | 10 | 15 | |
| 723 | EDIL3 levels | PROLV000675 | 4.07 | Protein levels | Lymphocyte | 4 | 2 | 10 | 30 | |
| 724 | RIDA levels | PROLV001733 | 4.07 | Protein levels | Hepatocyte | 51 | 3 | 17 | 29 | |
| 725 | CD74/NPDC1 ratio | PRORT000506 | 4.06 | Protein ratios | Lymphocyte | 43 | 3 | 22 | 25 | |
| 726 | Diffuse idiopathic skeletal hyperostosis | MSKEL000074 | 4.06 | Musculoskeletal | Hematopoietic progenitor | 1 | 2 | 6 | 16 | |
| 727 | Viral wart | IMMUN000079 | 4.05 | Immunologic | Lymphocyte | 7 | 4 | 11 | 39 | |
| 728 | FCRL6/KLRD1 ratio | PRORT001138 | 4.04 | Protein ratios | Lymphocyte | 19 | 5 | 13 | 39 | |
| 729 | SERPINH1 levels | PROLV001835 | 4.03 | Protein levels | Vascular | 20 | 1 | 7 | 16 | |
| 730 | LAT2/SERPINB1 ratio | PRORT001431 | 4.01 | Protein ratios | Hepatocyte | 1 | 4 | 13 | 30 | |
| 731 | MYO9B levels | PROLV001362 | 4.01 | Protein levels | Myeloid | 14 | 1 | 7 | 10 | |
| 732 | Asthma | IMMUN000005 | 3.99 | Immunologic | Lymphocyte | 397 | 2 | 13 | 13 | |
| 733 | Medical condition | MISCL000028 | 3.99 | Miscellaneous | Neural / glial | 16 | 3 | 10 | 16 | |
| 734 | CD300E levels | PROLV000331 | 3.98 | Protein levels | Myeloid | 202 | 2 | 7 | 8 | |
| 735 | EPCAM/GPA33 ratio | PRORT001035 | 3.98 | Protein ratios | B / plasma cell | 22 | 0 | 5 | 4 | |
| 736 | Respiratory disease | RESPI000004 | 3.98 | Respiratory | Lymphocyte | 194 | 2 | 11 | 11 | |
| 737 | Heart failure | CARDI000007 | 3.97 | Cardiac | Muscle / cardiac | 37 | 2 | 3 | 10 | |
| 738 | CTSZ levels | PROLV000570 | 3.96 | Protein levels | Hepatocyte | 81 | 1 | 7 | 12 | |
| 739 | Sleep apnoea | RESPI000035 | 3.95 | Respiratory | Neural / glial | 73 | 1 | 2 | 10 | |
| 740 | FOXO1/NUB1 ratio | PRORT001175 | 3.93 | Protein ratios | Myeloid | 0 | 2 | 13 | 20 | |
| 741 | CD40/ITGB5 ratio | PRORT000445 | 3.93 | Protein ratios | Myeloid | 8 | 2 | 9 | 17 | |
| 742 | DIPK2B levels | PROLV000619 | 3.92 | Protein levels | Vascular | 85 | 4 | 10 | 22 | |
| 743 | Smoking effects on COPD | RESPI000012 | 3.91 | Respiratory | Hepatocyte | 20 | 1 | 4 | 13 | |
| 744 | Frailty, unhealthy lifestyle | BEHAV000002 | 3.91 | Behavioural | Myeloid | 5 | 5 | 9 | 16 | |
| 745 | CLEC4A levels | PROLV000450 | 3.90 | Protein levels | Myeloid | 121 | 3 | 13 | 20 | |
| 746 | LY96/ST6GAL1 ratio | PRORT001471 | 3.90 | Protein ratios | Hepatocyte | 11 | 3 | 7 | 10 | |
| 747 | HLAE/IL15 ratio | PRORT001287 | 3.89 | Protein ratios | Lymphocyte | 41 | 2 | 13 | 24 | |
| 748 | DOK2/GRAP2 ratio | PRORT000938 | 3.89 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 4 | 7 | |
| 749 | ADAM12 levels | PROLV000025 | 3.88 | Protein levels | B / plasma cell | 2 | 2 | 6 | 12 | |
| 750 | Photodermatitis | DERMA000016 | 3.88 | Dermatologic | Lymphocyte | 2 | 2 | 11 | 29 | |
| 751 | Hyperthyroidism | ENDOC000020 | 3.88 | Endocrine | Lymphocyte | 62 | 1 | 10 | 16 | |
| 752 | IL7R levels | PROLV001081 | 3.87 | Protein levels | Hepatocyte | 78 | 3 | 10 | 27 | |
| 753 | Phosphatidylglycerols | LIPID000060 | 3.87 | Lipids | Granulosa cell | 3 | 3 | 10 | 22 | |
| 754 | FAS levels | PROLV000770 | 3.87 | Protein levels | Muscle / cardiac | 1 | 1 | 5 | 9 | |
| 755 | Dementia | NEURO000019 | 3.86 | Neurologic | Myeloid | 90 | 1 | 2 | 7 | |
| 756 | PRG2 levels | PROLV001628 | 3.86 | Protein levels | Lymphocyte | 70 | 4 | 8 | 35 | |
| 757 | Alcohol use | PSYCH000043 | 3.84 | Psychiatric | Neural / glial | 16 | 4 | 8 | 13 | |
| 758 | CXCL5/EDAR ratio | PRORT000827 | 3.84 | Protein ratios | Myeloid | 9 | 3 | 10 | 24 | |
| 759 | CD48/SLAMF7 ratio | PRORT000465 | 3.84 | Protein ratios | Lymphocyte | 35 | 4 | 17 | 42 | |
| 760 | Sphingolipids | LIPID000071 | 3.83 | Lipids | Neural / glial | 0 | 1 | 4 | 7 | |
| 761 | LAT/LYN ratio | PRORT001422 | 3.82 | Protein ratios | Lymphocyte | 0 | 2 | 17 | 49 | |
| 762 | BMP7 levels | PROLV000205 | 3.81 | Protein levels | Lymphocyte | 0 | 2 | 14 | 29 | |
| 763 | PXN levels | PROLV001688 | 3.81 | Protein levels | Neural / glial | 9 | 4 | 16 | 37 | |
| 764 | HHIP levels | PROLV000969 | 3.81 | Protein levels | B / plasma cell | 0 | 3 | 9 | 16 | |
| 765 | APOF levels | PROLV000125 | 3.81 | Protein levels | Hepatocyte | 56 | 4 | 10 | 22 | |
| 766 | ADH4/DCXR ratio | PRORT000039 | 3.81 | Protein ratios | Hepatocyte | 17 | 4 | 11 | 18 | |
| 767 | MCAM/NCAM1 ratio | PRORT001505 | 3.79 | Protein ratios | Adipose | 14 | 4 | 6 | 17 | |
| 768 | IGFBP7 levels | PROLV001033 | 3.79 | Protein levels | Hepatocyte | 24 | 1 | 7 | 17 | |
| 769 | Dietary change, none | DTSUP000005 | 3.78 | Diet and Supplement | Neural / glial | 19 | 3 | 12 | 8 | |
| 770 | HLA-DMA levels | PROLV000973 | 3.78 | Protein levels | Vascular | 4 | 0 | 2 | 1 | |
| 771 | CD8A levels | PROLV000361 | 3.77 | Protein levels | Lymphocyte | 149 | 2 | 10 | 16 | |
| 772 | Rotator cuff disorder | MSKEL000066 | 3.77 | Musculoskeletal | Neural / glial | 0 | 4 | 7 | 8 | |
| 773 | Medication, chronic lung disease | RESPI000006 | 3.76 | Respiratory | Neural / glial | 4 | 3 | 21 | 50 | |
| 774 | NMNAT1 levels | PROLV001411 | 3.76 | Protein levels | Lymphocyte | 18 | 1 | 10 | 26 | |
| 775 | Intestinal infection | IMMUN000066 | 3.76 | Immunologic | Vascular | 5 | 3 | 7 | 15 | |
| 776 | STK24/TDRKH ratio | PRORT001820 | 3.76 | Protein ratios | Myeloid | 0 | 4 | 15 | 39 | |
| 777 | Food preparation preference | DTSUP000021 | 3.74 | Diet and Supplement | Neural / glial | 51 | 4 | 9 | 6 | |
| 778 | SIGLEC6 levels | PROLV001862 | 3.73 | Protein levels | Myeloid | 115 | 2 | 5 | 11 | |
| 779 | BCR/ITGB1BP2 ratio | PRORT000227 | 3.73 | Protein ratios | Muscle / cardiac | 20 | 3 | 9 | 24 | |
| 780 | KL levels | PROLV001147 | 3.73 | Protein levels | Neural / glial | 1 | 1 | 3 | 12 | |
| 781 | LBR/PSRC1 ratio | PRORT001440 | 3.72 | Protein ratios | Myeloid | 1 | 4 | 10 | 15 | |
| 782 | PRND levels | PROLV001636 | 3.72 | Protein levels | Vascular | 49 | 4 | 10 | 21 | |
| 783 | Diabetes, type 1 | IMMUN000012 | 3.72 | Immunologic | Lymphocyte | 291 | 2 | 14 | 6 | |
| 784 | Medication, proton pump inhibitor | GASTR000017 | 3.72 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 21 | |
| 785 | OMD/SPP1 ratio | PRORT001615 | 3.72 | Protein ratios | Hepatocyte | 9 | 3 | 10 | 20 | |
| 786 | LAMP3 levels | PROLV001182 | 3.71 | Protein levels | Myeloid | 82 | 2 | 10 | 20 | |
| 787 | C1S levels | PROLV000229 | 3.71 | Protein levels | Myeloid | 0 | 3 | 14 | 17 | |
| 788 | IPCEF1/TBCB ratio | PRORT001364 | 3.70 | Protein ratios | Stromal / connective | 2 | 3 | 5 | 5 | |
| 789 | HSBP1 levels | PROLV000992 | 3.70 | Protein levels | Muscle / cardiac | 19 | 7 | 10 | 27 | |
| 790 | Ventricular function | CARDI000008 | 3.69 | Cardiac | Muscle / cardiac | 84 | 2 | 4 | 12 | |
| 791 | FCRL6 levels | PROLV000787 | 3.68 | Protein levels | Lymphocyte | 109 | 2 | 11 | 30 | |
| 792 | CD40LG/TNFSF14 ratio | PRORT000454 | 3.68 | Protein ratios | Hepatocyte | 11 | 5 | 17 | 43 | |
| 793 | Immunoglobulin deficiency | IMMUN000049 | 3.67 | Immunologic | B / plasma cell | 4 | 2 | 3 | 11 | |
| 794 | Oral health conditions, none | DENTA000009 | 3.67 | Dental | Lymphocyte | 19 | 2 | 15 | 31 | |
| 795 | WNT9A levels | PROLV002194 | 3.67 | Protein levels | Muscle / cardiac | 20 | 2 | 6 | 20 | |
| 796 | EBAG9/TGFB1 ratio | PRORT000963 | 3.67 | Protein ratios | Myeloid | 11 | 4 | 18 | 48 | |
| 797 | Clonal haematopoiesis | HEMAT000015 | 3.66 | Hematologic | Myeloid | 54 | 2 | 3 | 15 | |
| 798 | PSME1 levels | PROLV001658 | 3.66 | Protein levels | Stromal / connective | 0 | 3 | 9 | 18 | |
| 799 | ARSA/GUSB ratio | PRORT000143 | 3.65 | Protein ratios | Hepatocyte | 21 | 4 | 9 | 26 | |
| 800 | MCEE levels | PROLV001284 | 3.65 | Protein levels | Myeloid | 2 | 3 | 11 | 27 | |
| 801 | BTN3A2 levels | PROLV000220 | 3.64 | Protein levels | Lymphocyte | 122 | 3 | 11 | 23 | |
| 802 | Suicidal behaviour | PSYCH000037 | 3.64 | Psychiatric | Neural / glial | 0 | 4 | 8 | 14 | |
| 803 | AHSP/HMBS ratio | PRORT000058 | 3.64 | Protein ratios | Lymphocyte | 33 | 4 | 16 | 48 | |
| 804 | CDNF levels | PROLV000384 | 3.64 | Protein levels | Myeloid | 4 | 3 | 9 | 9 | |
| 805 | MGLL/PTPN6 ratio | PRORT001530 | 3.63 | Protein ratios | Hepatocyte | 40 | 1 | 6 | 12 | |
| 806 | Hearing aid use | AUDIO000011 | 3.63 | Auditory | Epithelial | 12 | 1 | 5 | 9 | |
| 807 | LGALS9 levels | PROLV001207 | 3.59 | Protein levels | Myeloid | 18 | 0 | 4 | 6 | |
| 808 | SCGB1A1 levels | PROLV001786 | 3.59 | Protein levels | Respiratory epithelium | 54 | 0 | 2 | 7 | |
| 809 | Refractive errors | OPHTH000034 | 3.59 | Ophthalmic | Neural / glial | 133 | 1 | 6 | 9 | |
| 810 | SUSD2 levels | PROLV001979 | 3.58 | Protein levels | B / plasma cell | 15 | 3 | 8 | 14 | |
| 811 | Diglycerides | LIPID000038 | 3.57 | Lipids | Hepatocyte | 32 | 1 | 5 | 16 | |
| 812 | Rosacea | DERMA000019 | 3.57 | Dermatologic | Lymphocyte | 37 | 2 | 14 | 19 | |
| 813 | CXCL5/PPIB ratio | PRORT000830 | 3.57 | Protein ratios | Platelet | 1 | 6 | 12 | 30 | |
| 814 | ADH4/KYNU ratio | PRORT000041 | 3.56 | Protein ratios | Hepatocyte | 41 | 4 | 16 | 28 | |
| 815 | HIP1R levels | PROLV000970 | 3.56 | Protein levels | Myeloid | 1 | 2 | 12 | 23 | |
| 816 | SIGLEC1 levels | PROLV001859 | 3.55 | Protein levels | Myeloid | 115 | 3 | 13 | 17 | |
| 817 | EPHB6/TNFRSF9 ratio | PRORT001038 | 3.54 | Protein ratios | Myeloid | 23 | 3 | 15 | 47 | |
| 818 | CSF1/IFNGR1 ratio | PRORT000776 | 3.54 | Protein ratios | Granulosa cell | 1 | 4 | 8 | 13 | |
| 819 | CREG1 levels | PROLV000517 | 3.54 | Protein levels | Hepatocyte | 128 | 2 | 13 | 21 | |
| 820 | PRG3 levels | PROLV001629 | 3.52 | Protein levels | Lymphocyte | 126 | 2 | 8 | 27 | |
| 821 | NPHS2 levels | PROLV001422 | 3.52 | Protein levels | B / plasma cell | 1 | 0 | 3 | 7 | |
| 822 | Frailty, metabolic problems | METBL000011 | 3.52 | Metabolic | Lymphocyte | 3 | 4 | 17 | 37 | |
| 823 | CRKL/DBNL ratio | PRORT000762 | 3.52 | Protein ratios | Muscle / cardiac | 2 | 5 | 11 | 23 | |
| 824 | CD58/MCAM ratio | PRORT000476 | 3.52 | Protein ratios | Adipose | 2 | 1 | 6 | 12 | |
| 825 | PTPRC levels | PROLV001674 | 3.50 | Protein levels | Lymphocyte | 55 | 2 | 13 | 35 | |
| 826 | Urinary tract infection | IMMUN000074 | 3.50 | Immunologic | Neural / glial | 1 | 1 | 3 | 7 | |
| 827 | PPY levels | PROLV001622 | 3.49 | Protein levels | Vascular | 12 | 0 | 2 | 9 | |
| 828 | PAK4 levels | PROLV001488 | 3.48 | Protein levels | Myeloid | 1 | 3 | 8 | 16 | |
| 829 | Shoulder lesion | MSKEL000068 | 3.48 | Musculoskeletal | B / plasma cell | 22 | 1 | 5 | 15 | |
| 830 | Erythrocyte | HEMAT000005 | 3.45 | Hematologic | Hematopoietic progenitor | 3,061 | 3 | 7 | 17 | |
| 831 | DARS1/USP8 ratio | PRORT000860 | 3.45 | Protein ratios | Hepatocyte | 3 | 3 | 8 | 17 | |
| 832 | CA13/TYMP ratio | PRORT000273 | 3.44 | Protein ratios | Myeloid | 6 | 2 | 7 | 7 | |
| 833 | Tyrosine | METAB000031 | 3.44 | Metabolites | Hepatocyte | 258 | 1 | 5 | 10 | |
| 834 | CASP8/DDX58 ratio | PRORT000321 | 3.43 | Protein ratios | Myeloid | 2 | 2 | 8 | 11 | |
| 835 | Other ear disorder | AUDIO000004 | 3.43 | Auditory | Epithelial | 6 | 0 | 7 | 9 | |
| 836 | DNMBP/PTPN1 ratio | PRORT000931 | 3.42 | Protein ratios | Myeloid | 8 | 5 | 12 | 20 | |
| 837 | Substance use | PSYCH000049 | 3.42 | Psychiatric | Muscle / cardiac | 0 | 4 | 6 | 14 | |
| 838 | ECM1 levels | PROLV000672 | 3.41 | Protein levels | Muscle / cardiac | 18 | 4 | 13 | 49 | |
| 839 | CPQ levels | PROLV000509 | 3.40 | Protein levels | Epithelial | 108 | 2 | 7 | 18 | |
| 840 | BIN2/FYB1 ratio | PRORT000232 | 3.40 | Protein ratios | Myeloid | 1 | 3 | 9 | 21 | |
| 841 | CD40/GLOD4 ratio | PRORT000443 | 3.40 | Protein ratios | Muscle / cardiac | 0 | 1 | 4 | 9 | |
| 842 | CCL16 levels | PROLV000282 | 3.40 | Protein levels | Hepatocyte | 117 | 2 | 8 | 16 | |
| 843 | Lactose intolerance | METBL000003 | 3.39 | Metabolic | Renal epithelium | 0 | 0 | 7 | 4 | |
| 844 | Diabetes, type 2, autoimmune subtype | IMMUN000013 | 3.39 | Immunologic | Myeloid | — | 1 | 7 | 29 | |
| 845 | ITGB1BP2/USP8 ratio | PRORT001390 | 3.39 | Protein ratios | Myeloid | 26 | 3 | 10 | 16 | |
| 846 | Meniscus surgery | MSKEL000050 | 3.38 | Musculoskeletal | Lymphocyte | 2 | 2 | 6 | 23 | |
| 847 | Supplement use, mineral or vitamin | DTSUP000026 | 3.38 | Diet and Supplement | Neural / glial | 7 | 5 | 9 | 22 | |
| 848 | Cancer, Kidney | MALIG000016 | 3.37 | Malignancy | Pancreatic epithelium | 1 | 0 | 6 | 12 | |
| 849 | Snack and fast-food preference | DTSUP000017 | 3.36 | Diet and Supplement | Neural / glial | 36 | 4 | 7 | 24 | |
| 850 | Dietary restriction | DTSUP000009 | 3.36 | Diet and Supplement | Neural / glial | 67 | 4 | 10 | 35 | |
| 851 | GDNF levels | PROLV000872 | 3.35 | Protein levels | Muscle / cardiac | 3 | 3 | 3 | 13 | |
| 852 | WFDC5 levels | PROLV002190 | 3.35 | Protein levels | Hepatocyte | 0 | 2 | 9 | 11 | |
| 853 | LYN/SIRT2 ratio | PRORT001472 | 3.34 | Protein ratios | Lymphocyte | 5 | 1 | 5 | 11 | |
| 854 | CD160 levels | PROLV000311 | 3.33 | Protein levels | Lymphocyte | 78 | 2 | 11 | 17 | |
| 855 | BAP18 levels | PROLV000179 | 3.33 | Protein levels | Vascular | 44 | 4 | 13 | 39 | |
| 856 | Benign neoplasm, Ocular | MALIG000005 | 3.32 | Malignancy | Melanocyte | 14 | 4 | 8 | 29 | |
| 857 | DKK1/VEGFC ratio | PRORT000905 | 3.32 | Protein ratios | Muscle / cardiac | 10 | 1 | 7 | 12 | |
| 858 | Hypothyroxinemia | ENDOC000022 | 3.32 | Endocrine | Neural / glial | 0 | 3 | 11 | 16 | |
| 859 | CA14 levels | PROLV000243 | 3.31 | Protein levels | Muscle / cardiac | 52 | 2 | 7 | 12 | |
| 860 | CD83/LAMP3 ratio | PRORT000517 | 3.31 | Protein ratios | Myeloid | 31 | 2 | 8 | 7 | |
| 861 | FOLH1 levels | PROLV000821 | 3.30 | Protein levels | Hepatocyte | 7 | 0 | 3 | 10 | |
| 862 | FIS1/HSPA1A ratio | PRORT001149 | 3.30 | Protein ratios | Hepatocyte | 34 | 3 | 9 | 20 | |
| 863 | ITGB5/VSIR ratio | PRORT001394 | 3.29 | Protein ratios | Myeloid | 8 | 4 | 7 | 14 | |
| 864 | TPK1 levels | PROLV002094 | 3.28 | Protein levels | Myeloid | 14 | 2 | 8 | 11 | |
| 865 | CLEC7A levels | PROLV000457 | 3.28 | Protein levels | Myeloid | 64 | 1 | 5 | 15 | |
| 866 | RNASE3 levels | PROLV001738 | 3.28 | Protein levels | Myeloid | 39 | 4 | 15 | 28 | |
| 867 | PALM3 levels | PROLV001491 | 3.26 | Protein levels | Myeloid | 37 | 2 | 7 | 12 | |
| 868 | Disability allowance, none | SOCIO000016 | 3.25 | Socioeconomic | Neural / glial | 0 | 4 | 18 | 26 | |
| 869 | FUT8/TNFSF14 ratio | PRORT001192 | 3.23 | Protein ratios | Adipose | 13 | 4 | 22 | 56 | |
| 870 | PCDH17/SEMA7A ratio | PRORT001626 | 3.23 | Protein ratios | Granulosa cell | 1 | 4 | 7 | 16 | |
| 871 | PLAUR levels | PROLV001573 | 3.22 | Protein levels | Muscle / cardiac | 4 | 3 | 7 | 25 | |
| 872 | Family history, chronic disease | MISCL000009 | 3.22 | Miscellaneous | Vascular | 0 | 5 | 13 | 8 | |
| 873 | AIFM1/PLXNA4 ratio | PRORT000060 | 3.21 | Protein ratios | Hepatocyte | 9 | 2 | 10 | 26 | |
| 874 | ATOX1 levels | PROLV000160 | 3.21 | Protein levels | Myeloid | 25 | 5 | 9 | 20 | |
| 875 | Carnitine | METAB000039 | 3.21 | Metabolites | Myeloid | 32 | 1 | 4 | 7 | |
| 876 | VIT levels | PROLV002162 | 3.21 | Protein levels | Myeloid | 11 | 6 | 14 | 27 | |
| 877 | KLRB1/KLRD1 ratio | PRORT001414 | 3.21 | Protein ratios | Myeloid | 47 | 4 | 15 | 24 | |
| 878 | Chronic respiratory disease | RESPI000003 | 3.21 | Respiratory | Lymphocyte | 99 | — | — | — | |
| 879 | CD86 levels | PROLV000360 | 3.20 | Protein levels | Myeloid | 72 | 5 | 16 | 20 | |
| 880 | Medication, calcium channel blocker | VASCU000035 | 3.20 | Vascular | Vascular | 18 | 1 | 4 | 14 | |
| 881 | DBNL/HSPA1A ratio | PRORT000867 | 3.20 | Protein ratios | Muscle / cardiac | 3 | 2 | 11 | 18 | |
| 882 | Kidney failure, acute | NEPHR000012 | 3.20 | Nephrourologic | Lymphocyte | 0 | 2 | 15 | 24 | |
| 883 | Vegetable preference | DTSUP000020 | 3.20 | Diet and Supplement | Neural / glial | 91 | 3 | 8 | 18 | |
| 884 | RNASEH2A levels | PROLV001741 | 3.20 | Protein levels | Neural / glial | 5 | 3 | 11 | 24 | |
| 885 | Triglycerides x psychiatric interaction | LIPID000040 | 3.19 | Lipids | Hepatocyte | 86 | 2 | 7 | 21 | |
| 886 | LYZL2 levels | PROLV001255 | 3.18 | Protein levels | Hepatocyte | 5 | 3 | 10 | 21 | |
| 887 | SRP14 levels | PROLV001943 | 3.18 | Protein levels | Lymphocyte | 4 | 2 | 14 | 26 | |
| 888 | Hospital admission | MISCL000022 | 3.18 | Miscellaneous | Neural / glial | 1 | 3 | 6 | 25 | |
| 889 | Papulosquamous disorder | DERMA000015 | 3.18 | Dermatologic | Lymphocyte | 65 | 2 | 12 | 14 | |
| 890 | Negative affect | PSYCH000030 | 3.18 | Psychiatric | Neural / glial | 83 | 3 | 8 | 9 | |
| 891 | CCL18 levels | PROLV000284 | 3.17 | Protein levels | Myeloid | 16 | 3 | 9 | 15 | |
| 892 | Erythematous skin disorder | DERMA000010 | 3.17 | Dermatologic | Lymphocyte | 18 | 2 | 19 | 22 | |
| 893 | CA13/TIA1 ratio | PRORT000272 | 3.17 | Protein ratios | Muscle / cardiac | 0 | 1 | 8 | 25 | |
| 894 | Medication use | MISCL000037 | 3.14 | Miscellaneous | Neural / glial | 67 | 6 | 15 | 20 | |
| 895 | CD4/LILRB4 ratio | PRORT000441 | 3.13 | Protein ratios | Myeloid | 61 | 4 | 11 | 12 | |
| 896 | BST2 levels | PROLV000216 | 3.11 | Protein levels | Myeloid | 103 | 2 | 6 | 18 | |
| 897 | EXTL1 levels | PROLV000738 | 3.11 | Protein levels | Myeloid | 13 | 4 | 13 | 17 | |
| 898 | BSG/LY9 ratio | PRORT000249 | 3.10 | Protein ratios | B / plasma cell | 12 | 1 | 6 | 19 | |
| 899 | TXNL1 levels | PROLV002126 | 3.10 | Protein levels | Lymphocyte | 35 | 2 | 13 | 14 | |
| 900 | FAM20A levels | PROLV000765 | 3.10 | Protein levels | Myeloid | 136 | 3 | 11 | 18 | |
| 901 | Lichen disorder | DERMA000013 | 3.09 | Dermatologic | Lymphocyte | 73 | 1 | 12 | 18 | |
| 902 | Wheeze | RESPI000034 | 3.09 | Respiratory | Lymphocyte | 80 | 2 | 12 | 20 | |
| 903 | ITM2A levels | PROLV001120 | 3.08 | Protein levels | Hepatocyte | 32 | 3 | 11 | 28 | |
| 904 | Tryptophan metabolites | METAB000015 | 3.08 | Metabolites | Hepatocyte | 39 | 0 | 2 | 11 | |
| 905 | LBP levels | PROLV001188 | 3.08 | Protein levels | Hepatocyte | 18 | 2 | 7 | 22 | |
| 906 | Addison disease | ENDOC000001 | 3.07 | Endocrine | Lymphocyte | 56 | 0 | 4 | 15 | |
| 907 | NUB1/SRPK2 ratio | PRORT001605 | 3.06 | Protein ratios | Myeloid | 0 | 1 | 5 | 8 | |
| 908 | CEP43/MPHOSPH8 ratio | PRORT000599 | 3.06 | Protein ratios | Myeloid | 3 | 3 | 8 | 23 | |
| 909 | Digestive system symptoms | GASTR000044 | 3.05 | Gastrointestinal | Neural / glial | 9 | 4 | 10 | 35 | |
| 910 | CD4 levels | PROLV000339 | 3.05 | Protein levels | Myeloid | 82 | 2 | 7 | 15 | |
| 911 | CIAPIN1/VEGFC ratio | PRORT000619 | 3.05 | Protein ratios | Platelet | 3 | 2 | 9 | 30 | |
| 912 | ALPP levels | PROLV000083 | 3.05 | Protein levels | Respiratory epithelium | 12 | 0 | 11 | 19 | |
| 913 | IGSF9 levels | PROLV001040 | 3.05 | Protein levels | Hepatocyte | 63 | 3 | 9 | 17 | |
| 914 | Vitreous disorder | OPHTH000047 | 3.05 | Ophthalmic | Neural / glial | 1 | 2 | 6 | 7 | |
| 915 | IDO1 levels | PROLV001011 | 3.05 | Protein levels | Myeloid | 66 | 2 | 11 | 32 | |
| 916 | Sinusitis | RESPI000039 | 3.03 | Respiratory | Lymphocyte | 11 | 2 | 13 | 30 | |
| 917 | METAP2/PFKFB2 ratio | PRORT001523 | 3.02 | Protein ratios | Muscle / cardiac | 1 | 3 | 9 | 18 | |
| 918 | Autoimmune polyglandular syndrome | IMMUN000025 | 3.02 | Immunologic | Hepatocyte | 0 | 1 | 10 | 25 | |
| 919 | OSM/TGFA ratio | PRORT001617 | 3.02 | Protein ratios | Myeloid | 11 | 2 | 11 | 22 | |
| 920 | Phenylalanine | METAB000027 | 3.01 | Metabolites | Hepatocyte | 104 | 1 | 4 | 10 | |
| 921 | FLT3LG levels | PROLV000817 | 3.00 | Protein levels | Hematopoietic progenitor | 69 | 3 | 7 | 12 | |
| 922 | CKAP4/LAMP3 ratio | PRORT000621 | 3.00 | Protein ratios | Epithelial | 36 | 0 | 9 | 11 | |
| 923 | MMP9/PLTP ratio | PRORT001549 | 2.99 | Protein ratios | Myeloid | 15 | 4 | 15 | 30 | |
| 924 | Family history, chronic lung disease | RESPI000002 | 2.99 | Respiratory | Stromal / connective | 0 | 2 | 6 | 14 | |
| 925 | NTN1 levels | PROLV001444 | 2.99 | Protein levels | B / plasma cell | 0 | 1 | 3 | 14 | |
| 926 | SERPINE1/SMAD1 ratio | PRORT001777 | 2.99 | Protein ratios | Myeloid | 4 | 4 | 14 | 28 | |
| 927 | SH2D1A levels | PROLV001852 | 2.98 | Protein levels | Lymphocyte | 41 | 2 | 10 | 28 | |
| 928 | PODXL2/SDC1 ratio | PRORT001696 | 2.98 | Protein ratios | Hepatocyte | 33 | 2 | 8 | 13 | |
| 929 | SCG3 levels | PROLV001785 | 2.98 | Protein levels | Vascular | 110 | 0 | 8 | 11 | |
| 930 | Insulin resistance | METBL000041 | 2.97 | Metabolic | Hepatocyte | 4 | 1 | 5 | 10 | |
| 931 | SOD2 levels | PROLV001917 | 2.97 | Protein levels | Myeloid | 96 | 2 | 6 | 7 | |
| 932 | Depression | PSYCH000024 | 2.97 | Psychiatric | Neural / glial | 57 | 3 | 8 | 12 | |
| 933 | CLEC14A/TNFRSF21 ratio | PRORT000629 | 2.96 | Protein ratios | Neural / glial | 5 | 1 | 1 | 8 | |
| 934 | Urbanicity | SOCIO000029 | 2.96 | Socioeconomic | Melanocyte | 0 | 3 | 9 | 12 | |
| 935 | L1CAM/SEZ6L ratio | PRORT001417 | 2.95 | Protein ratios | Myeloid | 3 | 1 | 8 | 17 | |
| 936 | SPINK2 levels | PROLV001928 | 2.95 | Protein levels | Lymphocyte | 29 | 4 | 16 | 31 | |
| 937 | SSC4D levels | PROLV001947 | 2.95 | Protein levels | Hepatocyte | 51 | 3 | 8 | 15 | |
| 938 | SLC51B levels | PROLV001883 | 2.95 | Protein levels | B / plasma cell | 4 | 0 | 6 | 9 | |
| 939 | CD79B/ICAM3 ratio | PRORT000512 | 2.94 | Protein ratios | B / plasma cell | 22 | 2 | 8 | 6 | |
| 940 | CXCL5/SERPINE1 ratio | PRORT000832 | 2.94 | Protein ratios | Myeloid | 0 | 5 | 10 | 14 | |
| 941 | Healthcare cost | SOCIO000025 | 2.93 | Socioeconomic | Neural / glial | 27 | 3 | 8 | 12 | |
| 942 | Study participation | BEHAV000004 | 2.92 | Behavioural | Neural / glial | 41 | 3 | 10 | 26 | |
| 943 | Surgical history | MISCL000031 | 2.91 | Miscellaneous | Hematopoietic progenitor | 22 | 1 | 1 | 6 | |
| 944 | Cancer, Lip | MALIG000017 | 2.91 | Malignancy | Lymphocyte | 0 | 3 | 11 | 39 | |
| 945 | CASP8/PPP3R1 ratio | PRORT000322 | 2.91 | Protein ratios | Lymphocyte | 5 | 1 | 8 | 25 | |
| 946 | CCN1/DNAJB1 ratio | PRORT000361 | 2.90 | Protein ratios | Hepatocyte | 26 | 4 | 14 | 37 | |
| 947 | PODXL2/SEZ6L ratio | PRORT001697 | 2.90 | Protein ratios | Myeloid | 3 | 2 | 5 | 17 | |
| 948 | Hair pigmentation | DERMA000025 | 2.90 | Dermatologic | Melanocyte | 189 | 2 | 7 | 22 | |
| 949 | SLC35G2 levels | PROLV001879 | 2.90 | Protein levels | Neural / glial | 0 | 2 | 4 | 6 | |
| 950 | Medication, anti-cancer | MALIG000048 | 2.90 | Malignancy | Epithelial | 9 | 0 | 5 | 9 | |
| 951 | Female genital tract polyp | REPRO000009 | 2.89 | Reproductive | Stromal / connective | 2 | 3 | 18 | 49 | |
| 952 | Birth complication | REPRO000036 | 2.89 | Reproductive | Muscle / cardiac | 0 | 0 | 7 | 16 | |
| 953 | APCS levels | PROLV000113 | 2.89 | Protein levels | Myeloid | 68 | 3 | 12 | 20 | |
| 954 | SNX18 levels | PROLV001912 | 2.89 | Protein levels | Hepatocyte | 0 | 1 | 8 | 17 | |
| 955 | HHV7 U14 antibody | IMMUN000063 | 2.88 | Immunologic | Lymphocyte | 4 | 1 | 13 | 39 | |
| 956 | Anxiety | PSYCH000022 | 2.88 | Psychiatric | Neural / glial | 45 | 4 | 8 | 19 | |
| 957 | EPO/TFRC ratio | PRORT001040 | 2.88 | Protein ratios | Lymphocyte | 0 | 4 | 7 | 15 | |
| 958 | ENTPD2 levels | PROLV000712 | 2.88 | Protein levels | Hepatocyte | 48 | 1 | 4 | 10 | |
| 959 | TSPAN1 levels | PROLV002115 | 2.87 | Protein levels | Myeloid | 19 | 1 | 8 | 10 | |
| 960 | Epigenetic age acceleration | AGING000002 | 2.87 | Aging | Hematopoietic progenitor | 25 | 1 | 3 | 22 | |
| 961 | CPXM1/SPARC ratio | PRORT000736 | 2.87 | Protein ratios | Hematopoietic progenitor | 3 | 2 | 8 | 22 | |
| 962 | Polymyalgia rheumatica | IMMUN000038 | 2.87 | Immunologic | Myeloid | 34 | 3 | 11 | 14 | |
| 963 | Family history, hypertension | VASCU000022 | 2.86 | Vascular | Hematopoietic progenitor | 2 | 0 | 1 | 5 | |
| 964 | GRSF1 levels | PROLV000936 | 2.85 | Protein levels | Myeloid | 3 | 3 | 9 | 10 | |
| 965 | Pain, joint | MSKEL000036 | 2.85 | Musculoskeletal | Neural / glial | 6 | 2 | 6 | 24 | |
| 966 | COVID-19 | IMMUN000054 | 2.84 | Immunologic | Lymphocyte | 1 | 1 | 12 | 37 | |
| 967 | MDGA1 levels | PROLV001288 | 2.84 | Protein levels | Hepatocyte | 14 | 2 | 9 | 10 | |
| 968 | GYS1/PPP1R2 ratio | PRORT001255 | 2.84 | Protein ratios | Melanocyte | 0 | 1 | 5 | 12 | |
| 969 | Consultant specialty, dermatology | DERMA000005 | 2.83 | Dermatologic | B / plasma cell | 5 | 0 | 2 | 9 | |
| 970 | Operation, urological | NEPHR000016 | 2.83 | Nephrourologic | Vascular | 16 | 0 | 6 | 18 | |
| 971 | CD1C/CD207 ratio | PRORT000391 | 2.82 | Protein ratios | Myeloid | 46 | 3 | 9 | 13 | |
| 972 | Immune cell marker, Monocyte | HEMAT000027 | 2.82 | Hematologic | Myeloid | 15 | 2 | 9 | 12 | |
| 973 | TFF3 levels | PROLV002014 | 2.82 | Protein levels | Pancreatic epithelium | 24 | 0 | 3 | 5 | |
| 974 | BCL2L2 levels | PROLV000189 | 2.81 | Protein levels | Vascular | 0 | 2 | 5 | 9 | |
| 975 | Creatine kinase | MSKEL000027 | 2.81 | Musculoskeletal | Muscle / cardiac | 145 | 4 | 10 | 21 | |
| 976 | ARSA levels | PROLV000145 | 2.80 | Protein levels | Hepatocyte | 73 | 4 | 12 | 23 | |
| 977 | Varicose veins, VV | VASCU000061 | 2.80 | Vascular | Vascular | 132 | 1 | 4 | 11 | |
| 978 | GP6/HPCAL1 ratio | PRORT001232 | 2.80 | Protein ratios | Lymphocyte | 1 | 3 | 13 | 26 | |
| 979 | CD160/CXCL16 ratio | PRORT000376 | 2.79 | Protein ratios | Lymphocyte | 12 | 2 | 13 | 32 | |
| 980 | STX16 levels | PROLV001967 | 2.79 | Protein levels | Muscle / cardiac | 7 | 4 | 5 | 17 | |
| 981 | Medication, anti-malarial | IMMUN000083 | 2.78 | Immunologic | Neural / glial | 0 | 2 | 6 | 16 | |
| 982 | Family history, coronary artery disease | VASCU000021 | 2.77 | Vascular | Vascular | 26 | 0 | 2 | 7 | |
| 983 | FASLG levels | PROLV000771 | 2.77 | Protein levels | Myeloid | 149 | 2 | 14 | 29 | |
| 984 | Otosclerosis | AUDIO000018 | 2.77 | Auditory | Granulosa cell | 16 | 5 | 10 | 16 | |
| 985 | GZMB/IL15 ratio | PRORT001263 | 2.77 | Protein ratios | Lymphocyte | 36 | 2 | 13 | 20 | |
| 986 | Diabetes, general | METBL000030 | 2.77 | Metabolic | Hepatocyte | 973 | 1 | 5 | 8 | |
| 987 | CALCB levels | PROLV000256 | 2.77 | Protein levels | Myeloid | 1 | 0 | 3 | 2 | |
| 988 | CCL19 levels | PROLV000285 | 2.77 | Protein levels | Lymphocyte | 61 | 1 | 10 | 16 | |
| 989 | Pneumonopathy | RESPI000016 | 2.77 | Respiratory | Pancreatic epithelium | 0 | 0 | 5 | 13 | |
| 990 | ACP5 levels | PROLV000014 | 2.76 | Protein levels | Myeloid | 150 | 2 | 11 | 22 | |
| 991 | ATP5IF1/F2R ratio | PRORT000155 | 2.74 | Protein ratios | Myeloid | 14 | 4 | 7 | 15 | |
| 992 | IL34 levels | PROLV001073 | 2.74 | Protein levels | Muscle / cardiac | 2 | 3 | 4 | 12 | |
| 993 | CFB levels | PROLV000410 | 2.74 | Protein levels | Hepatocyte | 101 | 4 | 14 | 24 | |
| 994 | Phosphatidylethanolamines | LIPID000059 | 2.74 | Lipids | Hepatocyte | 24 | 0 | 1 | 3 | |
| 995 | LGALS4/TIE1 ratio | PRORT001451 | 2.74 | Protein ratios | Hepatocyte | 12 | 0 | 5 | 10 | |
| 996 | Dietary pattern | DTSUP000007 | 2.73 | Diet and Supplement | Neural / glial | 279 | 3 | 7 | 16 | |
| 997 | ADAM15 levels | PROLV000026 | 2.73 | Protein levels | Lymphocyte | 72 | 2 | 16 | 38 | |
| 998 | Taste preference | DTSUP000023 | 2.73 | Diet and Supplement | Neural / glial | 83 | 3 | 6 | 17 | |
| 999 | KIAA2013 levels | PROLV001138 | 2.73 | Protein levels | Myeloid | — | 3 | 14 | 23 | |
| 1000 | CD163/MSR1 ratio | PRORT000384 | 2.72 | Protein ratios | Myeloid | 62 | 3 | 10 | 14 |